Skip to content
Usage Data - RIM
  • Pages
    • RIM Low Usage Customers with MS
    • Opps
    • Opportunity Owner
    • Vault Product Family
Usage Data - RIM
/
Opps
Share
Explore

Opps

Opportunities
Row
Owner Role
Opportunity Owner
Sales Manager
Account Name
Opportunity Name
Stage
Fiscal Period
Amount Currency
Amount
Expected Revenue Currency
Expected Revenue
Probability
Age
Close Date
Created Date
Next Step
Lead Source
Type
Account I D18 Digit
Ultimate Account ID
Ultimate Account ID 1
Ultimate Parent ID
Product
Product2
Product Line
Account ID
Parent Account ID
Low Usage
Cross-doc icon
4/4/2022
US Sales User - R&D SMB
David Florez
Coherus BioSciences, Inc.
Renewal 2022: Coherus Biosciences - eTMF - 10 Active / 11 Archive Sites
Closed Won
Q1-2023
​
​
​
​
100
339
4/4/2022
5/1/2021
​
​
Renewal
0015000000tq1wMAAQ
​
​
0015000000tq1wMAAQ
eTMF
Vault
R&D
0015000000tq1wM
​
Cross-doc icon
4/5/2022
US Sales User - R&D SMB
Jim Thai
Nektar Therapeutics
Renewal 2022: Nektar - Vault Subs/Subs A - 20 Full, 14 Archive
Closed Won
Q1-2023
​
​
​
​
100
356
4/5/2022
4/15/2021
​
​
Renewal
0015000000Lq8D5AAJ
0012J00002PUIc1QAH
0012J00002PUIc1QAH
0012J00002PUIc1QAH
Submissions
Vault
R&D
0015000000Lq8D5
0012J00002PUIc1
Cross-doc icon
4/5/2022
US Sales User - CRO
Katie Tipton
Pharma Start, LLC
Renewal 2022: Firma Clinical - Vault eTMF - DermaSensor - 22 Sites
Closed Won
Q1-2023
​
​
​
​
100
105
4/5/2022
12/21/2021
​
​
Subscription
0012J00002K4ubFQAR
​
​
0012J00002K4ubFQAR
​
​
R&D
0012J00002K4ubF
​
Cross-doc icon
4/6/2022
US Sales User - CDMS
Katie Tipton
Allucent
Renewal 2022: CATO SMS - QD VT ELA 1500
Closed Won
Q1-2023
​
​
​
​
100
364
4/6/2022
4/7/2021
​
​
Renewal
0015000000htJv3AAE
​
​
0015000000htJv3AAE
QualityDocs; Vault Training
Vault
R&D
0015000000htJv3
​
Cross-doc icon
4/7/2022
JP Sales User - R&D ENT
​
Sumitomo Pharma Co., Ltd.
Renewal 2022: Dainippon Sumitomo Global Submission 990 users
Closed Won
Q1-2023
​
​
​
​
100
362
4/7/2022
4/11/2021
​
​
Renewal
0015000000ORqoNAAT
0012J00002MKw1cQAD
0012J00002MKw1cQAD
0012J00002MKw1cQAD
Submissions
Vault
R&D
0015000000ORqoN
0012J00002MKw2r
Cross-doc icon
4/8/2022
US Sales User - R&D SMB
Jonathan Waldvogel
Checkmate Pharmaceuticals Inc.
Renewal 2022: Checkmate Pharmaceuticals_Vault eTMF
Closed Won
Q1-2023
​
​
​
​
100
329
4/8/2022
5/14/2021
​
​
Renewal
0015000001JKFZmAAP
​
​
0015000001JKFZmAAP
eTMF
Vault
R&D
0015000001JKFZm
​
Cross-doc icon
4/11/2022
US Sales User - R&D SMB
Jonathan Waldvogel
Checkmate Pharmaceuticals Inc.
Renewal 2022: Checkmate Pharmaceuticals_Vault Quality (QDocs & Training)
Closed Won
Q1-2023
​
​
​
​
100
285
4/11/2022
7/1/2021
​
​
Renewal
0015000001JKFZmAAP
​
​
0015000001JKFZmAAP
QualityDocs; Vault Training
Vault
R&D
0015000001JKFZm
​
Cross-doc icon
4/12/2022
US Sales User - R&D SMB
Adam De Oliveira
Protara Therapeutics, Inc.
Renewal 2022: Protara eTMF archive 43 sites 11 active
Closed Won
Q1-2023
​
​
​
​
100
357
4/12/2022
4/20/2021
​
​
Renewal
0012J00002N3aodQAB
​
​
0012J00002N3aodQAB
eTMF
Vault
R&D
0012J00002N3aod
​
Cross-doc icon
4/12/2022
US Sales User - R&D SMB
Jonathan Waldvogel
Intarcia Therapeutics, Inc.
Renewal 2022: Intarcia Therapeutics_Veeva QualityDocs Superseding Licensing Extension April 2022
Closed Won
Q1-2023
​
​
​
​
100
71
4/12/2022
1/31/2022
​
​
Subscription
0015000001IfBXpAAN
​
​
0015000001IfBXpAAN
​
​
R&D
0015000001IfBXp
​
Cross-doc icon
4/15/2022
US Sales User - R&D SMB
Jim Thai
Parker Institute for Cancer Immunotherapy
Renewal 2022: Parker Institute - QualityDocs_200 ELA & 33 eTMF- Safety
Closed Won
Q1-2023
​
​
​
​
100
308
4/15/2022
6/12/2021
​
​
Renewal
0015000001EbYF8AAN
​
​
0015000001EbYF8AAN
eTMF; QualityDocs
Vault
R&D
0015000001EbYF8
​
Cross-doc icon
4/15/2022
EU Sales User - R&D SMB
​
Ecuphar NV
Renewal 2022: Ecuphar - Ph I - QMS
Closed Won
Q1-2023
​
​
​
​
100
394
4/15/2022
3/17/2021
​
Sales
Subscription
00150000019EABEAA4
0015000001T4uznAAB
0015000001T4uznAAB
0015000001T4uznAAB
QMS; QualityDocs
Vault
R&D
00150000019EABE
0015000001T4uzn
Cross-doc icon
4/15/2022
EU Sales User - R&D SMB
​
Ecuphar NV
Renewal 2022: Ecuphar - RIM - Subs, Reg & Ramp
Closed Won
Q1-2023
​
​
​
​
100
394
4/15/2022
3/17/2021
​
Sales
Subscription
00150000019EABEAA4
0015000001T4uznAAB
0015000001T4uznAAB
0015000001T4uznAAB
Registrations; Submissions
Vault
R&D
00150000019EABE
0015000001T4uzn
Cross-doc icon
4/15/2022
US Sales User - MedTech ENT
​
Abbott MedTech
Renewal 2022: Abbott Vascular LATAM/CALA
Closed Won
Q1-2023
​
​
​
​
100
347
4/15/2022
5/3/2021
​
​
Renewal
0012J00002ZERRwQAP
0012J00002MK4X8QAL
0012J00002MK4X8QAL
0012J00002MK4X8QAL
PromoMats
Vault
R&D
0012J00002ZERRw
0012J00002MK4X8
Cross-doc icon
4/17/2022
EU Sales User - CDMS
​
Allucent
Renewal 2022: Specialized Medical Services-oncology B.V. eTMF CTMS SSU
Closed Won
Q1-2023
​
​
​
​
100
352
4/17/2022
5/1/2021
​
​
Renewal
0015000000htJv3AAE
​
​
0015000000htJv3AAE
CTMS; eTMF
Vault
R&D
0015000000htJv3
​
Cross-doc icon
4/20/2022
US Sales User - R&D SMB
Jonathan Waldvogel
Angion Biomedica Corp.
Renewal 2022: Angion QualityDocs
Closed Won
Q1-2023
​
​
​
​
100
355
4/20/2022
5/1/2021
​
​
Renewal
0015000001IHjoaAAD
​
​
0015000001IHjoaAAD
QualityDocs
Vault
R&D
0015000001IHjoa
​
Cross-doc icon
4/20/2022
US Sales User - CRO
Katie Tipton
St. Jude Children's Research Hospital, Inc.
Renewal 2022: St Jude CRH - RIM Suite (Subs, SubsA, Pub)
Closed Won
Q1-2023
​
​
​
​
100
345
4/20/2022
5/10/2021
​
​
Renewal
00150000014RszdAAC
​
​
00150000014RszdAAC
Submissions; Submissions Archive; Submissions Publishing
Vault
R&D
00150000014Rszd
​
Cross-doc icon
4/20/2022
JP Sales User - R&D ENT
​
Daiichi Sankyo Company, Limited. (Japan KK)
Renewal 2022: Daiichi Sankyo - CoMET QualityDocs - JP/US/EU
Closed Won
Q1-2023
​
​
​
​
100
294
4/20/2022
7/1/2021
​
​
Renewal
0015000000aQnvWAAS
0012J00002MK4XEQA1
0012J00002MK4XEQA1
0012J00002MK4XEQA1
QualityDocs
Vault
R&D
0015000000aQnvW
0012J00002aX68D
Cross-doc icon
4/22/2022
EU Sales User - CDMS
​
Exom Group Srl
Renewal 2022: Exom - eTMF - 162 sites - June to Aug -3 months
Closed Won
Q1-2023
​
​
​
​
100
87
4/22/2022
1/25/2022
​
Sales
Subscription
0015000000tptQnAAI
​
​
0015000000tptQnAAI
​
​
R&D
0015000000tptQn
​
Cross-doc icon
4/26/2022
US Sales User - R&D SMB
Phil Sager
Immunocore, Ltd
Renewal 2022: Immunocore_Vault Submissions/Submissions Archive
Closed Won
Q1-2023
​
​
​
​
100
358
4/26/2022
5/3/2021
​
Sales
Renewal
0012J00002LO4EvQAL
​
​
0012J00002LO4EvQAL
Submissions; Submissions Archive
Vault
R&D
0012J00002LO4Ev
​
Cross-doc icon
4/27/2022
US Sales User - R&D SMB
Jonathan Waldvogel
Cullinan Oncology
Renewal 2022: Cullinan Oncology - eTMF - (32)
Closed Won
Q1-2023
​
​
​
​
100
279
4/27/2022
7/23/2021
​
​
Renewal
0012J00002N4H28QAF
​
​
0012J00002N4H28QAF
eTMF
Vault
R&D
0012J00002N4H28
​
Cross-doc icon
4/27/2022
JP Sales User - R&D ENT
​
Daiichi Sankyo Company, Limited. (Japan KK)
Renewal 2022: Daiichi Sankyo - CoMET eTMF ELA - JP/US/EU
Closed Won
Q1-2023
​
​
​
​
100
301
4/27/2022
7/1/2021
​
​
Renewal
0015000000aQnvWAAS
0012J00002MK4XEQA1
0012J00002MK4XEQA1
0012J00002MK4XEQA1
eTMF; QualityDocs; Submissions
Vault
R&D
0015000000aQnvW
0012J00002aX68D
Cross-doc icon
4/27/2022
EU Sales User - R&D ENT
​
Novartis Pharma AG
Renewal 2022: Sandoz Biosimilars - eTMF
Closed Won
Q1-2023
​
​
​
​
100
181
4/27/2022
10/28/2021
​
Sales
Subscription
0015000001280zcAAA
0012J00002MIzmfQAD
0012J00002MIzmfQAD
0012J00002MIzmfQAD
​
​
R&D
0015000001280zc
001500000133m4p
Cross-doc icon
4/28/2022
US Sales User - R&D SMB
Jim Thai
Vir Biotechnology, Inc.
Renewal 2022: Vir Bio RIM
Closed Won
Q1-2023
​
​
​
​
100
363
4/28/2022
5/1/2021
​
​
Renewal
0015000001S0gThAAJ
​
​
0015000001S0gThAAJ
Submissions; Submissions Archive
Vault
R&D
0015000001S0gTh
​
Cross-doc icon
4/28/2022
US Sales User - R&D SMB
Adam De Oliveira
Kiniksa Pharmaceuticals Corp.
Renewal 2022: Kiniksa- RIM
Closed Won
Q1-2023
​
​
​
​
100
360
4/28/2022
5/3/2021
​
​
Renewal
0015000001HfFYcAAN
​
​
0015000001HfFYcAAN
Submissions; Submissions Archive
Vault
R&D
0015000001HfFYc
​
Cross-doc icon
4/28/2022
US Sales User - R&D SMB
Jim Thai
Vir Biotechnology, Inc.
Renewal 2022: Vir Bio QualityDocs & Training
Closed Won
Q1-2023
​
​
​
​
100
13
4/28/2022
4/15/2022
​
​
Subscription
0015000001S0gThAAJ
​
​
0015000001S0gThAAJ
​
​
R&D
0015000001S0gTh
​
Cross-doc icon
4/29/2022
US Sales User - R&D SMB
Phil Sager
Sumitovant Biopharma, Inc.
Renewal 2022: Sumitovant Biopharma - Vault QualityDocs & Training
Closed Won
Q1-2023
​
​
​
​
100
373
4/29/2022
4/21/2021
​
​
Renewal
0012J00002OfD5XQAV
0012J00002MKw1cQAD
0012J00002MKw1cQAD
0012J00002MKw1cQAD
QualityDocs; Vault Training
Vault
R&D
0012J00002OfD5X
0012J00002MKw1c
Cross-doc icon
5/2/2022
US Sales User - R&D SMB
Jim Thai
Vir Biotechnology, Inc.
Renewal 2022: Vir Bio QMS - 100 Users
Closed Won
Q2-2023
​
​
​
​
100
17
5/2/2022
4/15/2022
​
​
Subscription
0015000001S0gThAAJ
​
​
0015000001S0gThAAJ
​
​
R&D
0015000001S0gTh
​
Cross-doc icon
5/4/2022
US Sales User - R&D SMB
Christopher Mundy
Lexicon Pharmaceuticals, Inc
Renewal 2022: Lexicon eTMF
Closed Won
Q2-2023
​
​
​
​
100
328
5/4/2022
6/10/2021
​
​
Renewal
0015000000Lq8CgAAJ
​
​
0015000000Lq8CgAAJ
eTMF
Vault
R&D
0015000000Lq8Cg
​
Cross-doc icon
5/4/2022
US Sales User - CDMS
Katie Tipton
Pharm-Olam, LLC
Renewal 2022: Pharm-Olam eTMF - 1109
Closed Won
Q2-2023
​
​
​
​
100
135
5/4/2022
12/20/2021
​
​
Subscription
0015000000LVmaPAAT
0015000000htJv3AAE
0015000000htJv3AAE
0015000000htJv3AAE
​
​
R&D
0015000000LVmaP
0015000000htJv3
Cross-doc icon
5/4/2022
US Sales User - CDMS
Katie Tipton
Pharm-Olam, LLC
Renewal 2022: Pharm-Olam eTMF - Orphan 1126 & 1108
Closed Won
Q2-2023
​
​
​
​
100
9
5/4/2022
4/25/2022
​
​
Subscription
0015000000LVmaPAAT
0015000000htJv3AAE
0015000000htJv3AAE
0015000000htJv3AAE
​
​
R&D
0015000000LVmaP
0015000000htJv3
Cross-doc icon
5/5/2022
US Sales User - R&D SMB
Adam De Oliveira
Alimera Sciences, Inc.
Renewal 2022: Alimera RIM + QualityDocs ELA
Closed Won
Q2-2023
​
​
​
​
100
296
5/5/2022
7/13/2021
​
​
Renewal
0015000000QYShhAAH
​
​
0015000000QYShhAAH
Registrations; Submissions; Submissions Archive
Vault
R&D
0015000000QYShh
​
Cross-doc icon
5/5/2022
US Sales User - R&D SMB
Phil Sager
Supernus Pharmaceuticals, Inc.
Renewal 2022: Supernus Pharma - Vault eTMF, eTMF Archive, CTMS, & Payments
Closed Won
Q2-2023
​
​
​
​
100
149
5/5/2022
12/7/2021
​
Sales
Subscription
0015000000PiLnMAAV
​
​
0015000000PiLnMAAV
​
​
R&D
0015000000PiLnM
​
Cross-doc icon
5/5/2022
US Sales User - CDMS
Katie Tipton
Pharm-Olam, LLC
Renewal 2022: Pharm-Olam eTMF - 1212
Closed Won
Q2-2023
​
​
​
​
100
10
5/5/2022
4/25/2022
​
​
Subscription
0015000000LVmaPAAT
0015000000htJv3AAE
0015000000htJv3AAE
0015000000htJv3AAE
​
​
R&D
0015000000LVmaP
0015000000htJv3
Cross-doc icon
5/9/2022
EU Sales User - R&D SMB
​
Auregen BioTherapeutics SA
Renewal 2022: Auregen Biotherapeutics- Quality
Closed Won
Q2-2023
​
​
​
​
100
304
5/9/2022
7/9/2021
​
​
Renewal
0015000001XsdfDAAR
​
​
0015000001XsdfDAAR
QualityDocs
Vault
R&D
0015000001XsdfD
​
Cross-doc icon
5/10/2022
US Sales User - CDMS
Katie Tipton
Pharm-Olam, LLC
Renewal 2022: Pharm-Olam eTMF - Valneva 4 Sites
Closed Won
Q2-2023
​
​
​
​
100
89
5/10/2022
2/10/2022
​
​
Subscription
0015000000LVmaPAAT
0015000000htJv3AAE
0015000000htJv3AAE
0015000000htJv3AAE
​
​
R&D
0015000000LVmaP
0015000000htJv3
Cross-doc icon
5/10/2022
EU Sales User - R&D ENT
​
Kiadis Pharma Netherlands BV
Renewal 2022: Kiadis Pharma Netherlands BV - eTMF 33 sites - year 3- 3 months
Closed Won
Q2-2023
​
​
​
​
100
375
5/10/2022
5/1/2021
​
​
Renewal
00150000010hIesAAE
0015000001TVjdfAAD
0015000001TVjdfAAD
0015000001TVjdfAAD
eTMF
Vault
R&D
00150000010hIes
0015000001TVjdf
Cross-doc icon
5/10/2022
EU Sales User - R&D ENT
​
Kiadis Pharma Netherlands BV
Renewal 2022: Kiadis Pharma - ELA 200 QD & 45 users QMS
Closed Won
Q2-2023
​
​
​
​
100
375
5/10/2022
5/1/2021
​
​
Renewal
00150000010hIesAAE
0015000001TVjdfAAD
0015000001TVjdfAAD
0015000001TVjdfAAD
QMS; QualityDocs
Vault
R&D
00150000010hIes
0015000001TVjdf
Cross-doc icon
5/12/2022
US Sales User - R&D SMB
Jim Thai
Omeros Corporation
Renewal 2022: Omeros - Sub/SubA - 10 Full, 10 Archive
Closed Won
Q2-2023
​
​
​
​
100
370
5/12/2022
5/7/2021
​
​
Renewal
0015000000aQgjUAAS
​
​
0015000000aQgjUAAS
Submissions
Vault
R&D
0015000000aQgjU
​
Cross-doc icon
5/12/2022
US Sales User - R&D SMB
Jim Thai
Omeros Corporation
Renewal 2022: Omeros Vault QualityDocs - 300 ELA
Closed Won
Q2-2023
​
​
​
​
100
363
5/12/2022
5/15/2021
​
​
Renewal
0015000000aQgjUAAS
​
​
0015000000aQgjUAAS
QualityDocs
Vault
R&D
0015000000aQgjU
​
Cross-doc icon
5/12/2022
US Sales User - R&D SMB
Jim Thai
Omeros Corporation
Renewal 2022: Omeros - QMS - 50 Full Users + 15 in future bucket
Closed Won
Q2-2023
​
​
​
​
100
437
5/12/2022
3/1/2021
​
​
Renewal
0015000000aQgjUAAS
​
​
0015000000aQgjUAAS
QMS
Vault
R&D
0015000000aQgjU
​
Cross-doc icon
5/13/2022
US Sales User - R&D SMB
David Florez
Societal CDMO
Renewal 2022: Societal CDMO QualityDocs Renewal
Closed Won
Q2-2023
​
​
​
​
100
329
5/13/2022
6/19/2021
​
​
Renewal
0015000001P4J8XAAV
​
​
0015000001P4J8XAAV
QualityDocs
Vault
R&D
0015000001P4J8X
​
Cross-doc icon
5/13/2022
US Sales User - CRO
Katie Tipton
Social & Scientific Systems, Inc.
Renewal 2022: S3 DMID-BET - Consolidated 61 Sites
Closed Won
Q2-2023
​
​
​
​
100
78
5/13/2022
2/24/2022
​
​
Subscription
0015000000tQUB1AAO
​
​
0015000000tQUB1AAO
​
​
R&D
0015000000tQUB1
​
Cross-doc icon
5/17/2022
EU Sales User - R&D SMB
​
Laboratorios Hipra, S.A.
Hipra - Reg,Sub - Year 2 Renewal June 2022
Closed Won
Q2-2023
​
​
​
​
100
802
5/17/2022
3/6/2020
​
Sales
Subscription
0015000001EeMYvAAN
​
​
0015000001EeMYvAAN
Registrations; Submissions; Submissions Archive
Vault
R&D
0015000001EeMYv
​
Cross-doc icon
5/20/2022
US Sales User - CRO
Katie Tipton
Spaulding Clinical Research, LLC
Renewal 2022: Spaulding Clinical Research - eTMF
Closed Won
Q2-2023
​
​
​
​
100
371
5/20/2022
5/15/2021
​
​
Renewal
00150000015LXQaAAO
​
​
00150000015LXQaAAO
eTMF
Vault
R&D
00150000015LXQa
​
Cross-doc icon
5/20/2022
US Sales User - CDMS
Katie Tipton
Atlantic Research Group, Inc.
Renewal 2022: Atlantic Research Group eTMF Full Account Renewal 6/1/2022
Closed Won
Q2-2023
​
​
​
​
100
95
5/20/2022
2/14/2022
​
​
Subscription
0015000000qIWUEAA4
​
​
0015000000qIWUEAA4
​
​
R&D
0015000000qIWUE
​
Cross-doc icon
5/20/2022
US Sales User - CDMS
Katie Tipton
Atlantic Research Group, Inc.
Renewal 2022: Atlantic Research Group - CTMS
Closed Won
Q2-2023
​
​
​
​
100
95
5/20/2022
2/14/2022
​
Sales
Subscription
0015000000qIWUEAA4
​
​
0015000000qIWUEAA4
​
​
R&D
0015000000qIWUE
​
Cross-doc icon
5/23/2022
US Sales User - R&D SMB
Christopher Mundy
Bellicum Pharmaceuticals Inc.
Renewal 2022: Bellicum Vault- Qdocs & eTMF
Closed Won
Q2-2023
​
​
​
​
100
355
5/23/2022
6/2/2021
​
​
Renewal
0015000000bhOLMAA2
​
​
0015000000bhOLMAA2
Submissions; Submissions Archive
Vault
R&D
0015000000bhOLM
​
Cross-doc icon
5/23/2022
US Sales User - CRO
Katie Tipton
Paragon Bioteck, Inc.
Renewal 2022: Paragon Bioteck, Vault Submissions and SubmissionsArchive
Closed Won
Q2-2023
​
​
​
​
100
301
5/23/2022
7/26/2021
​
​
Renewal
0015000001KNAOJAA5
0015000001Dqpq2AAB
0015000001Dqpq2AAB
0015000001Dqpq2AAB
Submissions; Submissions Archive
Vault
R&D
0015000001KNAOJ
0015000001Dqpq2
Cross-doc icon
5/24/2022
US Sales User - R&D SMB
Adam De Oliveira
G1 Therapeutics, Inc.
Renewal 2022: G1-Sub-Quality-QMS-eTMF-Training- Platform
Closed Won
Q2-2023
​
​
​
​
100
385
5/24/2022
5/4/2021
​
​
Renewal
00150000019CZTNAA4
​
​
00150000019CZTNAA4
QualityDocs
Vault
R&D
00150000019CZTN
​
Cross-doc icon
5/24/2022
JP Sales User - R&D ENT
​
The Research Foundation for Microbial Diseases of Osaka University
Renewal 2022: BIKEN QualityDocs
Closed Won
Q2-2023
​
​
​
​
100
363
5/24/2022
5/26/2021
​
​
Renewal
0015000001nyfi1AAA
​
​
0015000001nyfi1AAA
QualityDocs
Vault
R&D
0015000001nyfi1
​
Cross-doc icon
5/24/2022
JP Sales User - R&D ENT
​
The Research Foundation for Microbial Diseases of Osaka University
Renewal 2022: BIKEN eTMF 43 Sites
Closed Won
Q2-2023
​
​
​
​
100
358
5/24/2022
6/1/2021
​
​
Renewal
0015000001nyfi1AAA
​
​
0015000001nyfi1AAA
eTMF
Vault
R&D
0015000001nyfi1
​
Cross-doc icon
5/26/2022
US Sales User - MedTech ENT
​
International Partnership for Microbicides, Inc.
Renewal 2022: IPM - eTMF - 30 Sites
Closed Won
Q2-2023
​
​
​
​
100
358
5/26/2022
6/2/2021
​
Sales
Renewal
0015000001RFZmPAAX
​
​
0015000001RFZmPAAX
eTMF
Vault
R&D
0015000001RFZmP
​
Cross-doc icon
5/26/2022
US Sales User - MedTech SMB
​
New Erie Scientific LLC
Renewal: Epredia RIM and Submissions for June 2021 through 5/31/22
Closed Won
Q2-2023
​
​
​
​
100
0
5/26/2022
5/26/2022
​
Sales
Subscription
0012J00002Pxs5BQAR
0012J00002PUCszQAH
0012J00002PUCszQAH
0012J00002PUCszQAH
​
​
R&D
0012J00002Pxs5B
0012J00002PUCsz
Cross-doc icon
5/27/2022
US Sales User - R&D SMB
Adam De Oliveira
Avalo Therapeutics, Inc.
Renewal 2022: Avalo - Quality & RIM
Closed Won
Q2-2023
​
​
​
​
100
260
5/27/2022
9/9/2021
​
​
Renewal
0015000000htJuFAAU
​
​
0015000000htJuFAAU
QualityDocs; Vault Training
Vault
R&D
0015000000htJuF
​
Cross-doc icon
5/27/2022
US Sales User - R&D ENT
​
Takeda Development Center Americas, Inc.
Takeda Pharma - CTMS_SSU_Payments_Site Connect - Global - ELA Year 1
Closed Won
Q2-2023
​
​
​
​
100
120
5/27/2022
1/27/2022
​
Sales
Subscription
0012J00002aXg5vQAC
0012J00002LPydAQAT
0012J00002LPydAQAT
0012J00002LPydAQAT
​
​
R&D
0012J00002aXg5v
0012J00002MJsv2
Cross-doc icon
5/31/2022
US Sales User - MedTech ENT
​
New Erie Scientific LLC
Epredia RIM and Submissions for June 2022 through 5/31/23
Closed Won
Q2-2023
​
​
​
​
100
722
5/31/2022
6/8/2020
​
​
Renewal
0012J00002Pxs5BQAR
0012J00002PUCszQAH
0012J00002PUCszQAH
0012J00002PUCszQAH
Submissions; Submissions Archive
Vault
R&D
0012J00002Pxs5B
0012J00002PUCsz
Cross-doc icon
5/31/2022
US Sales User - R&D SMB
Jim Thai
Nektar Therapeutics
Renewal 2022: Nektar Vault eTMF - 401 Active, 65 Archive
Closed Won
Q2-2023
​
​
​
​
100
350
5/31/2022
6/15/2021
​
​
Renewal
0015000000Lq8D5AAJ
0012J00002PUIc1QAH
0012J00002PUIc1QAH
0012J00002PUIc1QAH
eTMF
Vault
R&D
0015000000Lq8D5
0012J00002PUIc1
Cross-doc icon
5/31/2022
US Sales User - CRO
​
InVentiv Health Clinical, LLC, a subsidiary of Syneos Health Inc
Renewal 2022: Syneos eTMF - 3YR ELA - (Year 2)
Closed Won
Q2-2023
​
​
​
​
100
335
5/31/2022
6/30/2021
​
​
Renewal
0012J00002KlvT8QAJ
0012J00002MKPWbQAP
0012J00002MKPWbQAP
0012J00002MKPWbQAP
eTMF
Vault
R&D
0012J00002KlvT8
0012J00002MKPWb
Cross-doc icon
6/1/2022
US Sales User - R&D SMB
Adam De Oliveira
Prolong Pharmaceuticals, LLC
Renewal 2022: Prolong - Vault QualityDocs,QMS
Closed Won
Q2-2023
​
​
​
​
100
393
6/1/2022
5/4/2021
​
​
Renewal
0015000000bhOKvAAM
​
​
0015000000bhOKvAAM
QualityDocs
Vault
R&D
0015000000bhOKv
​
Cross-doc icon
6/1/2022
US Sales User - CRO
Katie Tipton
Technical Resources International, Inc.
Renewal 2022: TRI eTMF 6-1-2022
Closed Won
Q2-2023
​
​
​
​
100
169
6/1/2022
12/14/2021
​
​
Subscription
0015000000olZKlAAM
​
​
0015000000olZKlAAM
​
​
R&D
0015000000olZKl
​
Cross-doc icon
6/2/2022
US Sales User - R&D SMB
Phil Sager
Arvinas Operations, Inc
Renewal 2022: Arvinas - QDocs & Training & Subs/SubsA
Closed Won
Q2-2023
​
​
​
​
100
336
6/2/2022
7/1/2021
​
​
Renewal
0015000001MaGUTAA3
​
​
0015000001MaGUTAA3
QualityDocs; Vault Training
Vault
R&D
0015000001MaGUT
​
Cross-doc icon
6/2/2022
CN Sales User - R&D ENT
​
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Renewal Jun 2023: Dizal-China Biotech-QD+TRN-ELA250
Closed Won
Q2-2023
​
​
​
​
100
0
6/2/2022
6/2/2022
​
Sales
Subscription
0012J00002RDkCgQAL
0012J00002QK82jQAD
0012J00002QK82jQAD
0012J00002QK82jQAD
​
​
R&D
0012J00002RDkCg
0012J00002QK82j
Cross-doc icon
6/2/2022
CN Sales User - R&D ENT
​
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Renewal Jun 2024: Dizal-China Biotech-QD+TRN-ELA250
Closed Won
Q2-2023
​
​
​
​
100
0
6/2/2022
6/2/2022
​
Sales
Subscription
0012J00002RDkCgQAL
0012J00002QK82jQAD
0012J00002QK82jQAD
0012J00002QK82jQAD
​
​
R&D
0012J00002RDkCg
0012J00002QK82j
Cross-doc icon
6/6/2022
US Sales User - R&D SMB
David Florez
Coherus BioSciences, Inc.
Renewal 2022: Coherus - RIM (Subs/SubsA)
Closed Won
Q2-2023
​
​
​
​
100
102
6/6/2022
2/24/2022
​
​
Subscription
0015000000tq1wMAAQ
​
​
0015000000tq1wMAAQ
​
​
R&D
0015000000tq1wM
​
Cross-doc icon
6/9/2022
US Sales User - CDMS
Katie Tipton
Pharm-Olam, LLC
Renewal 2022: Pharm-Olam eTMF 1154
Closed Won
Q2-2023
​
​
​
​
100
171
6/9/2022
12/20/2021
​
Sales
Subscription
0015000000LVmaPAAT
0015000000htJv3AAE
0015000000htJv3AAE
0015000000htJv3AAE
​
​
R&D
0015000000LVmaP
0015000000htJv3
Cross-doc icon
6/9/2022
US Sales User - CDMS
Katie Tipton
Pharm-Olam, LLC
Renewal 2022: Pharm-Olam eTMF 1082
Closed Won
Q2-2023
​
​
​
​
100
7
6/9/2022
6/2/2022
​
Sales
Subscription
0015000000LVmaPAAT
0015000000htJv3AAE
0015000000htJv3AAE
0015000000htJv3AAE
​
​
R&D
0015000000LVmaP
0015000000htJv3
Cross-doc icon
6/9/2022
US Sales User - CDMS
Katie Tipton
Pharm-Olam, LLC
Renewal 2022: Pharm-Olam eTMF 1166
Closed Won
Q2-2023
​
​
​
​
100
7
6/9/2022
6/2/2022
​
Sales
Subscription
0015000000LVmaPAAT
0015000000htJv3AAE
0015000000htJv3AAE
0015000000htJv3AAE
​
​
R&D
0015000000LVmaP
0015000000htJv3
Cross-doc icon
6/9/2022
EU Sales User - R&D SMB
​
GlaxoSmithKline LLC
GSK Consumer Vault QMS P3 Renewal
Closed Won
Q2-2023
​
​
​
​
100
699
6/9/2022
7/10/2020
​
Sales
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
QMS
Vault
R&D
0015000000VSniv
0012J00002MJmoR
Cross-doc icon
6/16/2022
US Sales User - CRO
Katie Tipton
Social & Scientific Systems, Inc.
Renewal 2022: S3 DMID-BET - Consolidated 61 Sites
Closed Won
Q2-2023
​
​
​
​
100
34
6/16/2022
5/13/2022
​
​
Subscription
0015000000tQUB1AAO
​
​
0015000000tQUB1AAO
​
​
R&D
0015000000tQUB1
​
Cross-doc icon
6/17/2022
JP Sales User - R&D ENT
​
Daiichi Sankyo Company, Limited. (Japan KK)
Renewal 2022: Daiichi Sankyo - CoMET Subs ELA & Subs Archive 6th Year - JP/US
Closed Won
Q2-2023
​
​
​
​
100
353
6/17/2022
6/29/2021
​
​
Renewal
0015000000aQnvWAAS
0012J00002MK4XEQA1
0012J00002MK4XEQA1
0012J00002MK4XEQA1
eTMF; QualityDocs; Submissions
Vault
R&D
0015000000aQnvW
0012J00002aX68D
Cross-doc icon
6/19/2022
EU Sales User - R&D SMB
​
ERYTECH Pharma S.A
Renewal 2022: Erytech - QMS - ELA300- Year 1 + ramp
Closed Won
Q2-2023
​
​
​
​
100
376
6/19/2022
6/8/2021
​
Sales
Subscription
00150000019s0WQAAY
​
​
00150000019s0WQAAY
QMS
Vault
R&D
00150000019s0WQ
​
Cross-doc icon
6/21/2022
EU Sales User - R&D SMB
​
GlaxoSmithKline LLC
Renewal 2022: GSK Biopharma QualityDocs ELA
Closed Won
Q2-2023
​
​
​
​
100
147
6/21/2022
1/25/2022
​
Sales
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
​
​
R&D
0015000000VSniv
0012J00002MJmoR
Cross-doc icon
6/22/2022
US Sales User - R&D SMB
Ernie Chin
Purdue Pharma L.P.
Renewal 2022: Purdue/Imbrium - Vault Submissions - 60 users
Closed Won
Q2-2023
​
​
​
​
100
326
6/22/2022
8/1/2021
​
​
Renewal
0015000000IO284AAD
​
​
0015000000IO284AAD
Submissions
Vault
R&D
0015000000IO284
​
Cross-doc icon
6/22/2022
US Sales User - R&D SMB
Adam De Oliveira
G1 Therapeutics, Inc.
Renewal 2022: G1 Therapeutics - Safety (4 month renewal)
Closed Won
Q2-2023
​
​
​
​
100
104
6/22/2022
3/10/2022
​
Sales
Subscription
00150000019CZTNAA4
​
​
00150000019CZTNAA4
​
​
R&D
00150000019CZTN
​
Cross-doc icon
6/22/2022
EU Sales User - CDMS
​
European Organisation for Research and Treatment of Cancer
Renewal 2022: EORTC QMS ELA 300
Closed Won
Q2-2023
​
​
​
​
100
295
6/22/2022
9/1/2021
​
​
Renewal
0015000000wyMo2AAE
​
​
0015000000wyMo2AAE
QMS
Vault
R&D
0015000000wyMo2
​
Cross-doc icon
6/23/2022
US Sales User - MedTech ENT
​
New Erie Scientific LLC
Renewal: Epredia Vault Qdocs_ Runcorn 50 Full Users term 3
Closed Won
Q2-2023
​
​
​
​
100
507
6/23/2022
2/1/2021
​
Sales
Subscription
0012J00002Pxs5BQAR
0012J00002PUCszQAH
0012J00002PUCszQAH
0012J00002PUCszQAH
QualityDocs
Vault
R&D
0012J00002Pxs5B
0012J00002PUCsz
Cross-doc icon
6/27/2022
US Sales User - R&D SMB
Ernie Chin
Amarin Pharma Inc.
Renewal 2022: Amarin Corp_Vault Submissions/Submissions Archive
Closed Won
Q2-2023
​
​
​
​
100
317
6/27/2022
8/15/2021
​
​
Renewal
0015000000UlZyYAAV
0015000000MMajDAAT
0015000000MMajDAAT
0015000000MMajDAAT
Submissions; Submissions Archive
Vault
R&D
0015000000UlZyY
0015000000MMajD
Cross-doc icon
6/28/2022
Asia Pac Sales User - R&D SMB
​
Medytox Co., LTD.
Renewal Jul 2024: Medytox_KR_QMS_ELA500_Year3
Closed Won
Q2-2023
​
​
​
​
100
1
6/28/2022
6/27/2022
​
Sales
Subscription
0012J00002bQTRdQAO
0015000001KNJtiAAH
0015000001KNJtiAAH
0015000001KNJtiAAH
​
​
R&D
0012J00002bQTRd
0015000001KNJti
Cross-doc icon
6/30/2022
EU Sales User - R&D ENT
​
Genentech, Inc.
Roche Pharma RIM Suite Y3 Renewal (EU)
Closed Won
Q2-2023
​
​
​
​
100
707
6/30/2022
7/23/2020
​
Marketing
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
Registrations
Vault
R&D
0015000000IO27U
0015000001nyFxK
Cross-doc icon
6/30/2022
EU Sales User - R&D ENT
​
Genentech, Inc.
Roche Pharma PT - Vault QMS - EU-Yr 3 Renewal
Closed Won
Q2-2023
​
​
​
​
100
707
6/30/2022
7/23/2020
​
Sales
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
QMS
Vault
R&D
0015000000IO27U
0015000001nyFxK
Cross-doc icon
6/30/2022
US Manager - MedTech Sales
​
Genentech, Inc.
Roche Pharma RIM Suite Yr 3 Renewal (US)
Closed Won
Q2-2023
​
​
​
​
100
707
6/30/2022
7/23/2020
​
Marketing
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
Registrations
Vault
R&D
0015000000IO27U
0015000001nyFxK
Cross-doc icon
6/30/2022
US Manager - MedTech Sales
​
Genentech, Inc.
Roche Pharma PT - Vault QMS - US-Yr 3 Renewal
Closed Won
Q2-2023
​
​
​
​
100
707
6/30/2022
7/23/2020
​
Sales
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
QMS
Vault
R&D
0015000000IO27U
0015000001nyFxK
Cross-doc icon
7/1/2022
US Sales User - R&D SMB
Jim Thai
Turning Point Therapeutics, Inc.
Turning Point Therapeutics - QualityDocs and Training - ELA 300 (Ramp Yr. 1, Period 2)
Closed Won
Q2-2023
​
​
​
​
100
164
7/1/2022
1/18/2022
​
Sales
Subscription
0015000001eME6lAAG
​
​
0015000001eME6lAAG
​
​
R&D
0015000001eME6l
​
Cross-doc icon
7/1/2022
US Manager - MedTech Sales
​
Genentech, Inc.
Roche Pharma Publishing-US/EU-Yr 1 Renewal
Closed Won
Q2-2023
​
​
​
​
100
277
7/1/2022
9/27/2021
​
Sales
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
Submissions Publishing
Vault
R&D
0015000000IO27U
0015000001nyFxK
Cross-doc icon
7/1/2022
US Sales User - MedTech ENT
​
Foundation Medicine, Inc.
FMI Year 2 ELA for QMS & QDocs
Closed Won
Q2-2023
​
​
​
​
100
317
7/1/2022
8/18/2021
​
Sales
Subscription
0015000000ddJezAAE
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
QMS; QualityDocs
Vault
R&D
0015000000ddJez
0012J00002ZERRv
Cross-doc icon
7/3/2022
Asia Pac Sales User - R&D ENT
​
SillaJen, Inc.
Renewal 2022: Sillajen - Vault QualityDocs - 50 Employee ELA
Closed Won
Q2-2023
​
​
​
​
100
368
7/3/2022
7/1/2021
​
​
Renewal
0015000002GVFnkAAH
​
​
0015000002GVFnkAAH
QualityDocs
Vault
R&D
0015000002GVFnk
​
Cross-doc icon
7/3/2022
Asia Pac Sales User - R&D ENT
​
SillaJen, Inc.
Renewal 2022: Sillajen - Vault eTMF & CTMS
Closed Won
Q2-2023
​
​
​
​
100
337
7/3/2022
8/1/2021
​
​
Renewal
0015000002GVFnkAAH
​
​
0015000002GVFnkAAH
eTMF
Vault
R&D
0015000002GVFnk
​
Cross-doc icon
7/6/2022
EU Sales User - R&D SMB
​
GW Research Limited
Renewal 2022: GW eTMF
Closed Won
Q2-2023
​
​
​
​
100
389
7/6/2022
6/13/2021
​
​
Renewal
0015000000ePga4AAC
0012J00002MKw19QAD
0012J00002MKw19QAD
0012J00002MKw19QAD
eTMF
Vault
R&D
0015000000ePga4
0012J00002MKw19
Cross-doc icon
7/6/2022
US Sales User - R&D SMB
Jonathan Waldvogel
Homology Medicines Inc.
Renewal 2022: Homology RIM
Closed Won
Q2-2023
​
​
​
​
100
363
7/6/2022
7/9/2021
​
​
Renewal
0015000001XrfCWAAZ
​
​
0015000001XrfCWAAZ
Submissions; Submissions Archive
Vault
R&D
0015000001XrfCW
​
Cross-doc icon
7/6/2022
US Sales User - R&D SMB
Adam De Oliveira
Kiniksa Pharmaceuticals Corp.
Renewal 2022: Kiniksa Pharmaceuticals - eTMF
Closed Won
Q2-2023
​
​
​
​
100
335
7/6/2022
8/5/2021
​
​
Renewal
0015000001HfFYcAAN
​
​
0015000001HfFYcAAN
eTMF
Vault
R&D
0015000001HfFYc
​
Cross-doc icon
7/7/2022
US Sales User - R&D SMB
Jonathan Waldvogel
Homology Medicines Inc.
Renewal 2022: Homology Medicines - Quality & Training ELA 200 #NC
Closed Won
Q2-2023
​
​
​
​
100
364
7/7/2022
7/9/2021
​
​
Renewal
0015000001XrfCWAAZ
​
​
0015000001XrfCWAAZ
QualityDocs; Station Manager
Vault
R&D
0015000001XrfCW
​
Cross-doc icon
7/8/2022
EU Sales User - R&D ENT
​
GlaxoSmithKline LLC
Renewal 2022: Tesaro GSK QMS 3 months
Closed Won
Q2-2023
​
​
​
​
100
233
7/8/2022
11/17/2021
​
Sales
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
​
​
R&D
0015000000VSniv
0012J00002MJmoR
Cross-doc icon
7/11/2022
US Sales User - CRO
Katie Tipton
Social & Scientific Systems, Inc.
Renewal Jul 2022: S3 DMID-BET - Consolidated 61 Sites
Closed Won
Q2-2023
​
​
​
​
100
25
7/11/2022
6/16/2022
​
​
Subscription
0015000000tQUB1AAO
​
​
0015000000tQUB1AAO
​
​
R&D
0015000000tQUB1
​
Cross-doc icon
7/11/2022
JP Sales User - R&D ENT
​
Sumitomo Pharma Co., Ltd.
Renewal 2022: SMP Clinical QMS 25 users
Closed Won
Q2-2023
​
​
​
​
100
345
7/11/2022
8/1/2021
​
​
Renewal
0015000000ORqoNAAT
0012J00002MKw1cQAD
0012J00002MKw1cQAD
0012J00002MKw1cQAD
QMS
Vault
R&D
0015000000ORqoN
0012J00002MKw2r
Cross-doc icon
7/12/2022
EU Sales User - R&D ENT
​
Sanofi Aventis Groupe
2024 Renewal: Sanofi - QDocs QMS Training ELA
Closed Won
Q2-2023
​
​
​
​
100
368
7/12/2022
7/9/2021
​
​
Renewal
0015000000Kjce7AAB
0015000001TVjdfAAD
0015000001TVjdfAAD
0015000001TVjdfAAD
QualityDocs
Vault
R&D
0015000000Kjce7
0012J00002bz91p
Cross-doc icon
7/12/2022
EU Sales User - R&D ENT
​
Sanofi Aventis Groupe
2023 Renewal: Sanofi - QDocs QMS Training ELA
Closed Won
Q2-2023
​
​
​
​
100
1596
7/12/2022
2/27/2018
​
Sales
Subscription
0015000000Kjce7AAB
0015000001TVjdfAAD
0015000001TVjdfAAD
0015000001TVjdfAAD
QualityDocs
Vault
R&D
0015000000Kjce7
0012J00002bz91p
Cross-doc icon
7/13/2022
US Sales User - R&D SMB
Phil Sager
Mimedx Group, Inc.
Renewal 2022: MiMedx - Vault eTMF, CTMS, & Payments
Closed Won
Q2-2023
​
​
​
​
100
345
7/13/2022
8/2/2021
​
​
Renewal
0015000001EIny5AAD
​
​
0015000001EIny5AAD
Submissions; Submissions Archive
Vault
R&D
0015000001EIny5
​
Cross-doc icon
7/13/2022
US Sales User - R&D SMB
Phil Sager
Mimedx Group, Inc.
Renewal 2022: MiMedx - Submissions and Submissions Archive
Closed Won
Q2-2023
​
​
​
​
100
89
7/13/2022
4/15/2022
​
​
Subscription
0015000001EIny5AAD
​
​
0015000001EIny5AAD
​
​
R&D
0015000001EIny5
​
Cross-doc icon
7/14/2022
US Sales User - R&D SMB
Adam De Oliveira
TherapeuticsMD, Inc.
TherapeuticsMD New SubmissionsArchive - 4Month renewal
Closed Won
Q2-2023
​
​
​
​
100
324
7/14/2022
8/24/2021
​
Sales
Subscription
0015000000dbU1sAAE
​
​
0015000000dbU1sAAE
Submissions Archive
Vault
R&D
0015000000dbU1s
​
Cross-doc icon
7/19/2022
US Sales User - R&D SMB
Jonathan Waldvogel
Repertoire Immune Medicines
Renewal 2022: Repertoire - eTMF #NC
Closed Won
Q2-2023
​
​
​
​
100
309
7/19/2022
9/13/2021
​
​
Renewal
0012J00002P8I3DQAV
​
​
0012J00002P8I3DQAV
eTMF
Vault
R&D
0012J00002P8I3D
​
Cross-doc icon
7/19/2022
US Sales User - CRO
Katie Tipton
Technical Resources International, Inc.
Renewal 2022: TRI Vault Submissions 7-1-2022
Closed Won
Q2-2023
​
​
​
​
100
242
7/19/2022
11/19/2021
​
​
Subscription
0015000000olZKlAAM
​
​
0015000000olZKlAAM
​
​
R&D
0015000000olZKl
​
Cross-doc icon
7/19/2022
US Sales User - R&D SMB
Jonathan Waldvogel
Amylyx Pharmaceuticals, Inc
Amylyx - QualityDocs & Training (Yr. 2)
Closed Won
Q2-2023
​
​
​
​
100
127
7/19/2022
3/14/2022
​
Sales
Subscription
0012J00002P4o1TQAR
​
​
0012J00002P4o1TQAR
​
​
R&D
0012J00002P4o1T
​
Cross-doc icon
7/20/2022
US Sales User - R&D SMB
Ernie Chin
Jazz Pharmaceuticals, Inc.
Renewal 2022: Jazz Pharmaceuticals - Vault eTMF
Closed Won
Q2-2023
​
​
​
​
100
387
7/20/2022
6/28/2021
​
​
Renewal
0015000000IO27gAAD
0012J00002MKw19QAD
0012J00002MKw19QAD
0012J00002MKw19QAD
eTMF
Vault
R&D
0015000000IO27g
0012J00002bzPP2
Cross-doc icon
7/20/2022
US Sales User - R&D SMB
​
J&J Pharmaceuticals
Renewal 2022: Momenta RIM, QD, QMS, Training ELA200
Closed Won
Q2-2023
​
​
​
​
100
113
7/20/2022
3/29/2022
​
​
Subscription
0012J00002MJmrHQAT
0015000001RO8AFAA1
0015000001RO8AFAA1
0015000001RO8AFAA1
​
​
R&D
0012J00002MJmrH
0015000001RO8AF
Cross-doc icon
7/20/2022
LatAm Sales User
​
Específicos Stendhal S.A de C.V.
Renewal 2022: Stendhal LatAm Registrations 10 Users
Closed Won
Q2-2023
​
​
​
​
100
415
7/20/2022
6/1/2021
​
​
Renewal
0015000000fTHSgAAO
0012J00002K4P7SQAV
0012J00002K4P7SQAV
0012J00002K4P7SQAV
Registrations; Submissions
Vault
R&D
0015000000fTHSg
0012J00002K4P7S
Cross-doc icon
7/21/2022
US Sales User - R&D SMB
Adam De Oliveira
International AIDS Vaccine Initiative, Inc.
Renewal 2022: IAVI - NA - eTMF
Closed Won
Q2-2023
​
​
​
​
100
97
7/21/2022
4/15/2022
​
​
Subscription
00150000019DKfQAAW
​
​
00150000019DKfQAAW
​
​
R&D
00150000019DKfQ
​
Cross-doc icon
7/22/2022
US Sales User - R&D SMB
Christopher Mundy
Sorrento Therapeutics, Inc.
Renewal 2022: Sorrento Therapeutics - Vault Submissions/Submissions Archive
Closed Won
Q2-2023
​
​
​
​
100
377
7/22/2022
7/11/2021
​
​
Renewal
00150000013SNjAAAW
​
​
00150000013SNjAAAW
Registrations; Submissions
Vault
R&D
00150000013SNjA
​
Cross-doc icon
7/22/2022
EU Sales User - CDMS
​
Exom Group Srl
Renewal 2022: Exom - eTMF - 162 sites - Sept -Nov 3 months
Closed Won
Q2-2023
​
​
​
​
100
91
7/22/2022
4/22/2022
​
Sales
Subscription
0015000000tptQnAAI
​
​
0015000000tptQnAAI
​
​
R&D
0015000000tptQn
​
Cross-doc icon
7/28/2022
US Sales User - R&D ENT
​
Audentes Therapeutics, Inc.
Renewal 2022: Audentes Therapeutics-QMS-300 ELA *
Closed Won
Q2-2023
​
​
​
​
100
346
7/28/2022
8/16/2021
​
​
Renewal
0015000000sDkKcAAK
0012J00002N44FaQAJ
0012J00002N44FaQAJ
0012J00002N44FaQAJ
QMS
Vault
R&D
0015000000sDkKc
0012J00002N44Fa
Cross-doc icon
7/29/2022
US Sales User - R&D SMB
Adam De Oliveira
Strongbridge U.S. Inc.
Renewal 2022: Strongbridge Quality (QualityDocs & QMS)
Closed Won
Q2-2023
​
​
​
​
100
424
7/29/2022
6/1/2021
​
​
Renewal
00150000016BpEmAAK
00150000018Qz0AAAS
00150000018Qz0AAAS
00150000018Qz0AAAS
QualityDocs
Vault
R&D
00150000016BpEm
00150000018Qz0A
Cross-doc icon
7/29/2022
EU Sales User - R&D SMB
​
Recordati Rare Diseases, Inc.
Renewal 2022: Recordati US- Vault Training - 153 users
Closed Won
Q2-2023
​
​
​
​
100
365
7/29/2022
7/29/2021
​
​
Renewal
0015000000pJSINAA4
0015000000VSdDeAAL
0015000000VSdDeAAL
0015000000VSdDeAAL
Vault Training
Vault
R&D
0015000000pJSIN
0015000000VSdDe
Cross-doc icon
8/3/2022
EU Sales User - R&D ENT
​
Novartis
Renewal 2023: Novartis eTMF, Vault SSU
Closed Won
Q3-2023
​
​
​
​
100
1
8/3/2022
8/2/2022
​
Sales
Subscription
0012J00002MIzmfQAD
​
​
0012J00002MIzmfQAD
​
​
R&D
0012J00002MIzmf
​
Cross-doc icon
8/3/2022
EU Sales User - R&D ENT
​
Novartis
Renewal 2024: Novartis eTMF, Vault SSU
Closed Won
Q3-2023
​
​
​
​
100
1
8/3/2022
8/2/2022
​
Sales
Subscription
0012J00002MIzmfQAD
​
​
0012J00002MIzmfQAD
​
​
R&D
0012J00002MIzmf
​
Cross-doc icon
8/3/2022
EU Sales User - R&D ENT
​
Novartis
Renewal 2025: Novartis eTMF, Vault SSU
Closed Won
Q3-2023
​
​
​
​
100
1
8/3/2022
8/2/2022
​
Sales
Subscription
0012J00002MIzmfQAD
​
​
0012J00002MIzmfQAD
​
​
R&D
0012J00002MIzmf
​
Cross-doc icon
8/3/2022
EU Sales User - R&D ENT
​
Novartis
Renewal 2026: Novartis eTMF, Vault SSU
Closed Won
Q3-2023
​
​
​
​
100
0
8/3/2022
8/3/2022
​
Sales
Subscription
0012J00002MIzmfQAD
​
​
0012J00002MIzmfQAD
​
​
R&D
0012J00002MIzmf
​
Cross-doc icon
8/5/2022
US Sales User - R&D SMB
Jonathan Waldvogel
Homology Medicines Inc.
Renewal 2022: Homology eTMF
Closed Won
Q3-2023
​
​
​
​
100
393
8/5/2022
7/9/2021
​
​
Renewal
0015000001XrfCWAAZ
​
​
0015000001XrfCWAAZ
eTMF
Vault
R&D
0015000001XrfCW
​
Cross-doc icon
8/10/2022
US Sales User - R&D SMB
Adam De Oliveira
Nevakar, Inc.
Renewal 2022: Nevakar - Vault RIM
Closed Won
Q3-2023
​
​
​
​
100
309
8/10/2022
10/5/2021
​
​
Renewal
0015000001TU8VKAA1
​
​
0015000001TU8VKAA1
Submissions; Submissions Archive
Vault
R&D
0015000001TU8VK
​
Cross-doc icon
8/10/2022
US Manager - R&D Sales
Christopher Mundy
Denovo Biopharma LLC
Renewal 2022: Denovo (formerly Tocagen) eTMF, Sub & Archive
Closed Won
Q3-2023
​
​
​
​
100
400
8/10/2022
7/6/2021
​
​
Renewal
00150000025afp4AAA
​
​
00150000025afp4AAA
eTMF; QualityDocs; Submissions
Vault
R&D
00150000025afp4
​
Cross-doc icon
8/16/2022
US Sales User - R&D SMB
Phil Sager
Biocryst Pharmaceuticals, Inc.
Renewal 2022: Biocryst Pharmaceuticals - Vault CTMS/eTMF - Orphan Sites
Closed Won
Q3-2023
​
​
​
​
100
377
8/16/2022
8/4/2021
​
​
Renewal
0015000000Lq8AvAAJ
​
​
0015000000Lq8AvAAJ
eTMF
Vault
R&D
0015000000Lq8Av
​
Cross-doc icon
8/16/2022
EU Sales User - R&D ENT
​
Genentech, Inc.
Roche Vault Payments - Y2
Closed Won
Q3-2023
​
​
​
​
100
637
8/16/2022
11/17/2020
​
Sales
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
CTMS
Vault
R&D
0015000000IO27U
0015000001nyFxK
Cross-doc icon
8/16/2022
EU Sales User - R&D ENT
​
Genentech, Inc.
Roche Vault Payments - Y3
Closed Won
Q3-2023
​
​
​
​
100
50
8/16/2022
6/27/2022
​
Sales
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
​
​
R&D
0015000000IO27U
0015000001nyFxK
Cross-doc icon
8/19/2022
US Sales User - R&D SMB
Adam De Oliveira
Tiziana Life Sciences plc
Renewal 2022: Tiziana Life Sciences_Vault RIM (Submissions/Submissions Archive)
Closed Won
Q3-2023
​
​
​
​
100
324
8/19/2022
9/29/2021
​
​
Renewal
0012J00002LQ6AYQA1
​
​
0012J00002LQ6AYQA1
Submissions; Submissions Archive
Vault
R&D
0012J00002LQ6AY
​
Cross-doc icon
8/19/2022
US Sales User - R&D SMB
Jonathan Waldvogel
WAVE Life Sciences Ltd.
Renewal 2022: Wave Life Sciences- Contract Management (Platform)
Closed Won
Q3-2023
​
​
​
​
100
364
8/19/2022
8/21/2021
​
​
Renewal
001500000189NO7AAM
​
​
001500000189NO7AAM
Platform R&D
Vault
R&D
001500000189NO7
​
Cross-doc icon
8/19/2022
EU Sales User - R&D SMB
​
GW Research Limited
Renewal 2022: GW Pharma QualityDocs & QMS - ELA500
Closed Won
Q3-2023
​
​
​
​
100
355
8/19/2022
8/30/2021
​
​
Renewal
0015000000ePga4AAC
0012J00002MKw19QAD
0012J00002MKw19QAD
0012J00002MKw19QAD
QualityDocs
Vault
R&D
0015000000ePga4
0012J00002MKw19
Cross-doc icon
8/22/2022
US Sales User - R&D SMB
Adam De Oliveira
Braeburn Inc.
Renewal 2022: Braeburn Vault Submissions/Submissions Archive
Closed Won
Q3-2023
​
​
​
​
100
342
8/22/2022
9/14/2021
​
​
Renewal
0015000000jYgnuAAC
​
​
0015000000jYgnuAAC
Submissions
Vault
R&D
0015000000jYgnu
​
Cross-doc icon
8/22/2022
US Sales User - R&D SMB
Phil Sager
Roivant Sciences, Inc.
Renewal 2022: Roivant Sciences - Vault RIM, Quality, eTMF
Closed Won
Q3-2023
​
​
​
​
100
368
8/22/2022
8/19/2021
​
​
Renewal
0015000001APsQwAAL
​
​
0015000001APsQwAAL
eTMF; QMS; QualityDocs; Submissions; Submissions Archive; Vault Training
Vault
R&D
0015000001APsQw
​
Cross-doc icon
8/22/2022
US Sales User - CDMS
Katie Tipton
Atlantic Research Group, Inc.
Renewal 2022: Atlantic Research Group - CTMS
Closed Won
Q3-2023
​
​
​
​
100
94
8/22/2022
5/20/2022
​
Sales
Subscription
0015000000qIWUEAA4
​
​
0015000000qIWUEAA4
​
​
R&D
0015000000qIWUE
​
Cross-doc icon
8/22/2022
US Sales User - CDMS
Katie Tipton
Atlantic Research Group, Inc.
Renewal 2022: Atlantic Research Group eTMF Full Account Renewal 9/1/2022
Closed Won
Q3-2023
​
​
​
​
100
94
8/22/2022
5/20/2022
​
​
Subscription
0015000000qIWUEAA4
​
​
0015000000qIWUEAA4
​
​
R&D
0015000000qIWUE
​
Cross-doc icon
8/22/2022
EU Sales User - R&D SMB
​
GW Research Limited
Renewal 2022: GW Pharma QualityDocs 6 months courtesy for migration access
Closed Won
Q3-2023
​
​
​
​
100
31
8/22/2022
7/22/2022
​
​
Subscription
0015000000ePga4AAC
0012J00002MKw19QAD
0012J00002MKw19QAD
0012J00002MKw19QAD
​
​
R&D
0015000000ePga4
0012J00002MKw19
Cross-doc icon
8/23/2022
US Sales User - R&D SMB
Christopher Mundy
Theravance Biopharma US, Inc.
Renewal 2022: Theravance - Subs 20 users/SubsA 10 users
Closed Won
Q3-2023
​
​
​
​
100
371
8/23/2022
8/17/2021
​
Sales
Renewal
0015000000LX0LMAA1
​
​
0015000000LX0LMAA1
Submissions; Submissions Archive
Vault
R&D
0015000000LX0LM
​
Cross-doc icon
8/23/2022
CN Sales User - R&D ENT
​
TAIZHOU EOC pharma Co.,ltd
Renewal Aug 2023: EOCpharma-China-eTMF+CTMS-China Biotech ELA 5
Closed Won
Q3-2023
​
​
​
​
100
0
8/23/2022
8/23/2022
​
Sales
Subscription
0012J00002aZ3sPQAS
0015000000tsIxGAAU
0015000000tsIxGAAU
0015000000tsIxGAAU
​
​
R&D
0012J00002aZ3sP
0015000000tsIxG
Cross-doc icon
8/23/2022
CN Sales User - R&D ENT
​
TAIZHOU EOC pharma Co.,ltd
Renewal Aug 2024: EOCpharma-China-eTMF+CTMS-China Biotech ELA 5
Closed Won
Q3-2023
​
​
​
​
100
0
8/23/2022
8/23/2022
​
Sales
Subscription
0012J00002aZ3sPQAS
0015000000tsIxGAAU
0015000000tsIxGAAU
0015000000tsIxGAAU
​
​
R&D
0012J00002aZ3sP
0015000000tsIxG
Cross-doc icon
8/24/2022
US Sales User - R&D SMB
Jonathan Waldvogel
Vedanta Biosciences, Inc.
Renewal 2022: Vedanta - QualityDocs & Training ELA - QMS 30 Users
Closed Won
Q3-2023
​
​
​
​
100
348
8/24/2022
9/11/2021
​
​
Renewal
0015000001JGoyaAAD
​
​
0015000001JGoyaAAD
QMS; QualityDocs
Vault
R&D
0015000001JGoya
​
Cross-doc icon
8/24/2022
EU Sales User - R&D SMB
​
Jazz
Renewal 2022: Jazz Pharmaceuticals Vault QualityDocs and QMS ELA 3,500
Closed Won
Q3-2023
​
​
​
​
100
191
8/24/2022
2/14/2022
​
Sales
Subscription
0012J00002MKw19QAD
​
​
0012J00002MKw19QAD
​
​
R&D
0012J00002MKw19
​
Cross-doc icon
8/24/2022
EU Sales User - R&D SMB
​
Ferring International Center SA
Ferring - Vault Registrations - PUPM Year 2
Closed Won
Q3-2023
​
​
​
​
100
488
8/24/2022
4/23/2021
​
Sales
Subscription
0015000000aQAuPAAW
0012J00002MKF7XQAX
0012J00002MKF7XQAX
0012J00002MKF7XQAX
Registrations; Submissions; Submissions Archive
Vault
R&D
0015000000aQAuP
0012J00002MKF7X
Cross-doc icon
8/25/2022
US Sales User - R&D SMB
Jim Thai
Arcturus Therapeutics, Inc.
Renewal 2022: Arcturus Therapeutics - Vault QualityDocs & Vault Training - 200 ELA
Closed Won
Q3-2023
​
​
​
​
100
363
8/25/2022
8/27/2021
​
​
Renewal
0015000000r8H7sAAE
​
​
0015000000r8H7sAAE
QualityDocs; Vault Training
Vault
R&D
0015000000r8H7s
​
Cross-doc icon
8/25/2022
EU Sales User - R&D SMB
​
MorphoSys AG
Renewal 2022 Morphosys - RIM ELA 1000
Closed Won
Q3-2023
​
​
​
​
100
218
8/25/2022
1/19/2022
​
Sales
Subscription
0015000000OQ3L7AAL
​
​
0015000000OQ3L7AAL
​
​
R&D
0015000000OQ3L7
​
Cross-doc icon
8/26/2022
US Sales User - CRO
Katie Tipton
ASH Research Collaborative
Renewal 2022: ASH - eTMF - 52 Sites
Closed Won
Q3-2023
​
​
​
​
100
346
8/26/2022
9/15/2021
​
​
Renewal
0012J00002QLRmAQAX
​
​
0012J00002QLRmAQAX
eTMF
Vault
R&D
0012J00002QLRmA
​
Cross-doc icon
8/28/2022
US Sales User - R&D SMB
Christopher Mundy
Kodiak Sciences
Renewal 2022: Kodiak Sciences - QualityDocs - 200 ELA
Closed Won
Q3-2023
​
​
​
​
100
347
8/28/2022
9/15/2021
​
​
Renewal
0015000000bhNQvAAM
​
​
0015000000bhNQvAAM
QualityDocs
Vault
R&D
0015000000bhNQv
​
Cross-doc icon
8/30/2022
US Sales User - R&D SMB
Christopher Mundy
Lexicon Pharmaceuticals, Inc
Renewal 2022: Lexicon - Safety - 250 active cases
Closed Won
Q3-2023
​
​
​
​
100
350
8/30/2022
9/14/2021
​
Sales
Renewal
0015000000Lq8CgAAJ
​
​
0015000000Lq8CgAAJ
Vault Safety
Vault
R&D
0015000000Lq8Cg
​
Cross-doc icon
8/30/2022
US Sales User - R&D SMB
Phil Sager
Biocryst Pharmaceuticals, Inc.
Renewal 2022: Biocryst - Submissions & Submissions Archive - ELA400
Closed Won
Q3-2023
​
​
​
​
100
398
8/30/2022
7/28/2021
​
​
Renewal
0015000000Lq8AvAAJ
​
​
0015000000Lq8AvAAJ
Submissions; Submissions Archive
Vault
R&D
0015000000Lq8Av
​
Cross-doc icon
8/30/2022
US Sales User - R&D SMB
Phil Sager
Biocryst Pharmaceuticals, Inc.
Renewal 2022: Biocryst Pharmaceuticals - QMS & QualityDocs - ELA400
Closed Won
Q3-2023
​
​
​
​
100
398
8/30/2022
7/28/2021
​
​
Renewal
0015000000Lq8AvAAJ
​
​
0015000000Lq8AvAAJ
QualityDocs
Vault
R&D
0015000000Lq8Av
​
Cross-doc icon
8/30/2022
US Sales User - R&D SMB
Phil Sager
Spark Therapeutics, Inc.
Renewal 2022: Spark Platform Contracts Management
Closed Won
Q3-2023
​
​
​
​
100
368
8/30/2022
8/27/2021
​
​
Renewal
0015000000tq9LNAAY
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
Platform
Vault
R&D
0015000000tq9LN
0015000001nyFxK
Cross-doc icon
8/31/2022
EU Sales User - R&D ENT
​
Genentech, Inc.
Renewal - Roche Pharma eTMF/CTMS Y3 ramp (EU+US)
Closed Won
Q3-2023
​
​
​
​
100
1064
8/31/2022
10/2/2019
​
Sales
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
CTMS; eTMF
Vault
R&D
0015000000IO27U
0015000001nyFxK
Cross-doc icon
9/2/2022
US Sales User - R&D SMB
Jim Thai
Calico Life Sciences LLC
Renewal 2022: Calico Life Sciences - QualityDocs + Training
Closed Won
Q3-2023
​
​
​
​
100
337
9/2/2022
10/1/2021
​
​
Renewal
0015000001nxYfoAAE
​
​
0015000001nxYfoAAE
QualityDocs
Vault
R&D
0015000001nxYfo
​
Cross-doc icon
9/2/2022
EU Sales User - R&D ENT
​
UCB Biopharma SRL
Renewal 2022: UCB Zogenix Legacy eTMF - $0 OF For migration
Closed Won
Q3-2023
​
​
​
​
100
110
9/2/2022
5/16/2022
​
Sales
Subscription
00150000018OaEYAA0
0012J00002MJ2bHQAT
0012J00002MJ2bHQAT
0012J00002MJ2bHQAT
​
​
R&D
00150000018OaEY
0012J00002bzOpx
Cross-doc icon
9/5/2022
EU Sales User - R&D ENT
​
BIONTECH US INC.
Renewal 2022: BioNTech US - eTMF - migration courtesy access
Closed Won
Q3-2023
​
​
​
​
100
355
9/5/2022
9/15/2021
​
​
Renewal
0015000001HE1PXAA1
0015000001HENG5AAP
0015000001HENG5AAP
0015000001HENG5AAP
eTMF
Vault
R&D
0015000001HE1PX
0015000001HENG5
Cross-doc icon
9/6/2022
US Sales User - R&D SMB
Jim Thai
Xeris Pharmaceuticals, Inc.
Renewal 2022: Xeris - eTMF Renewal
Closed Won
Q3-2023
​
​
​
​
100
336
9/6/2022
10/5/2021
​
​
Renewal
00150000018Qz0AAAS
​
​
00150000018Qz0AAAS
eTMF
Vault
R&D
00150000018Qz0A
​
Cross-doc icon
9/6/2022
EU Sales User - R&D ENT
​
BioNTech SE
BioNTech SE - eTMF, CTMS, SSU- ELA Year 2
Closed Won
Q3-2023
​
​
​
​
100
81
9/6/2022
6/17/2022
​
Sales
Subscription
0015000001HENG5AAP
​
​
0015000001HENG5AAP
​
​
R&D
0015000001HENG5
​
Cross-doc icon
9/6/2022
EU Sales User - R&D ENT
​
BioNTech SE
BioNTech SE - eTMF, CTMS, SSU- ELA Year 3
Closed Won
Q3-2023
​
​
​
​
100
81
9/6/2022
6/17/2022
​
Sales
Subscription
0015000001HENG5AAP
​
​
0015000001HENG5AAP
​
​
R&D
0015000001HENG5
​
Cross-doc icon
9/7/2022
US Sales User - R&D SMB
Jonathan Waldvogel
Black Diamond Therapeutics, Inc.
Renewal 2022: Black Diamond Therapeutics_Vault eTMF
Closed Won
Q3-2023
​
​
​
​
100
342
9/7/2022
9/30/2021
​
​
Renewal
0015000002IiNnuAAF
​
​
0015000002IiNnuAAF
CTMS; eTMF; SiteConnect
Vault
R&D
0015000002IiNnu
​
Cross-doc icon
9/7/2022
US Sales User - R&D SMB
Phil Sager
Spark Therapeutics, Inc.
Renewal 2022: Spark - Quality - QMS
Closed Won
Q3-2023
​
​
​
​
100
362
9/7/2022
9/10/2021
​
​
Renewal
0015000000tq9LNAAY
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
QMS
Vault
R&D
0015000000tq9LN
0015000001nyFxK
Cross-doc icon
9/8/2022
EU Sales User - R&D SMB
​
Calliditas Therapeutics AB
Renewal 2022: Calliditas Therapeutics AB - QD ELA 200 Subs
Closed Won
Q3-2023
​
​
​
​
100
343
9/8/2022
10/1/2021
​
​
Renewal
0015000002GUdjmAAD
​
​
0015000002GUdjmAAD
Submissions
Vault
R&D
0015000002GUdjm
​
Cross-doc icon
9/12/2022
US Sales User - R&D SMB
Phil Sager
Immunocore, Ltd
Renewal 2022: Immunocore - Vault RIM
Closed Won
Q3-2023
​
​
​
​
100
139
9/12/2022
4/26/2022
​
Sales
Subscription
0012J00002LO4EvQAL
​
​
0012J00002LO4EvQAL
​
​
R&D
0012J00002LO4Ev
​
Cross-doc icon
9/13/2022
US Sales User - CRO
Katie Tipton
St. Jude Children's Research Hospital, Inc.
Renewal 2022: St Jude CRH Clinical Apps
Closed Won
Q3-2023
​
​
​
​
100
397
9/13/2022
8/12/2021
​
​
Renewal
00150000014RszdAAC
​
​
00150000014RszdAAC
eTMF
Vault
R&D
00150000014Rszd
​
Cross-doc icon
9/14/2022
US Sales User - CDMS
Katie Tipton
Allucent
Renewal May 2023: Allucent - Clinical Suite Study ELA 200
Closed Won
Q3-2023
​
​
​
​
100
0
9/14/2022
9/14/2022
​
Sales
Subscription
0015000000htJv3AAE
​
​
0015000000htJv3AAE
​
​
R&D
0015000000htJv3
​
Cross-doc icon
9/14/2022
US Sales User - CDMS
Katie Tipton
Allucent
Renewal May 2024: Allucent - Clinical Suite Study ELA 200
Closed Won
Q3-2023
​
​
​
​
100
0
9/14/2022
9/14/2022
​
Sales
Subscription
0015000000htJv3AAE
​
​
0015000000htJv3AAE
​
​
R&D
0015000000htJv3
​
Cross-doc icon
9/16/2022
EU Sales User - R&D ENT
​
Ferring International Center SA
Ferring - QualityDocs ELA Year 2 Renewal + Ramp
Closed Won
Q3-2023
​
​
​
​
100
406
9/16/2022
8/6/2021
​
Sales
Subscription
0015000000aQAuPAAW
0012J00002MKF7XQAX
0012J00002MKF7XQAX
0012J00002MKF7XQAX
QMS; QualityDocs
Vault
R&D
0015000000aQAuP
0012J00002MKF7X
Cross-doc icon
9/16/2022
US Sales User - R&D SMB
Ernie Chin
Sumitomo Pharma Oncology, Inc.
Renewal 2022: SDPO- eTMF & Platform Renewal
Closed Won
Q3-2023
​
​
​
​
100
367
9/16/2022
9/15/2021
​
​
Renewal
0015000000ph6mWAAQ
0012J00002MKw1cQAD
0012J00002MKw1cQAD
0012J00002MKw1cQAD
eTMF
Vault
R&D
0015000000ph6mW
0012J00002MKw2r
Cross-doc icon
9/19/2022
US Sales User - R&D SMB
Phil Sager
Spark Therapeutics, Inc.
Renewal 2022: Spark - NA - eTMF/CTMS Sites - ELA
Closed Won
Q3-2023
​
​
​
​
100
374
9/19/2022
9/10/2021
​
​
Renewal
0015000000tq9LNAAY
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
CTMS; eTMF
Vault
R&D
0015000000tq9LN
0015000001nyFxK
Cross-doc icon
9/20/2022
US Sales User - R&D SMB
Jonathan Waldvogel
FerGene Inc.
Renewal Oct 2022: FerGene- Qdocs, Training, QMS, Subs & SubA #NC
Closed Won
Q3-2023
​
​
​
​
100
173
9/20/2022
3/31/2022
​
​
Subscription
0012J00002OdrDNQAZ
0012J00002MKF7XQAX
0012J00002MKF7XQAX
0012J00002MKF7XQAX
​
​
R&D
0012J00002OdrDN
0012J00002MKF7X
Cross-doc icon
9/21/2022
US Sales User - R&D SMB
Phil Sager
Myovant Sciences, Inc.
Renewal 2022: Myovant Sciences (SV) - Vault eTMF - 25 Active Sites
Closed Won
Q3-2023
​
​
​
​
100
348
9/21/2022
10/8/2021
​
​
Renewal
0015000001OFSfGAAX
0012J00002MKw1cQAD
0012J00002MKw1cQAD
0012J00002MKw1cQAD
eTMF
Vault
R&D
0015000001OFSfG
0012J00002OfD5X
Cross-doc icon
9/22/2022
US Sales User - R&D SMB
Jonathan Waldvogel
HilleVax, Inc.
Renewal 2022: HilleVax eTMF Archive
Closed Won
Q3-2023
​
​
​
​
100
358
9/22/2022
9/29/2021
​
​
Renewal
0012J00002U6WwuQAF
​
​
0012J00002U6WwuQAF
eTMF
Vault
R&D
0012J00002U6Wwu
​
Cross-doc icon
9/22/2022
US Sales User - R&D SMB
Christopher Mundy
Polynoma LLC
Renewal 2022: Polynoma - Vault eTMF - 75 Active to Archive Sites
Closed Won
Q3-2023
​
​
​
​
100
118
9/22/2022
5/27/2022
​
Sales
Subscription
0015000000fTTJBAA4
​
​
0015000000fTTJBAA4
​
​
R&D
0015000000fTTJB
​
Cross-doc icon
9/26/2022
US Sales User - CRO
​
InVentiv Health Clinical, LLC, a subsidiary of Syneos Health Inc
Renewal Oct 2023: Syneos - Unified Clinical - SSU, CTMS, Payments - YR2
Closed Won
Q3-2023
​
​
​
​
100
0
9/26/2022
9/26/2022
​
Sales
Subscription
0012J00002KlvT8QAJ
0012J00002MKPWbQAP
0012J00002MKPWbQAP
0012J00002MKPWbQAP
​
​
R&D
0012J00002KlvT8
0012J00002MKPWb
Cross-doc icon
9/26/2022
US Sales User - CRO
​
InVentiv Health Clinical, LLC, a subsidiary of Syneos Health Inc
Renewal Oct 2024: Syneos - Unified Clinical - SSU, CTMS, Payments - YR3
Closed Won
Q3-2023
​
​
​
​
100
0
9/26/2022
9/26/2022
​
Sales
Subscription
0012J00002KlvT8QAJ
0012J00002MKPWbQAP
0012J00002MKPWbQAP
0012J00002MKPWbQAP
​
​
R&D
0012J00002KlvT8
0012J00002MKPWb
Cross-doc icon
9/26/2022
CN Sales User - R&D ENT
​
TAIZHOU EOC pharma Co.,ltd
Renewal Sep 2023: EOCPharma-China-Submission&Sub Archive-15users&2users
Closed Won
Q3-2023
​
​
​
​
100
0
9/26/2022
9/26/2022
​
Sales
Subscription
0012J00002aZ3sPQAS
0015000000tsIxGAAU
0015000000tsIxGAAU
0015000000tsIxGAAU
​
​
R&D
0012J00002aZ3sP
0015000000tsIxG
Cross-doc icon
9/26/2022
CN Sales User - R&D ENT
​
TAIZHOU EOC pharma Co.,ltd
Renewal Sep 2024: EOCPharma-China-Submission&Sub Archive-15users&2users
Closed Won
Q3-2023
​
​
​
​
100
0
9/26/2022
9/26/2022
​
Sales
Subscription
0012J00002aZ3sPQAS
0015000000tsIxGAAU
0015000000tsIxGAAU
0015000000tsIxGAAU
​
​
R&D
0012J00002aZ3sP
0015000000tsIxG
Cross-doc icon
9/28/2022
US Sales User - R&D SMB
Jonathan Waldvogel
Black Diamond Therapeutics, Inc.
Renewal 2022: Black Diamond_Vault RIM (Submissions/Publishing/Submissions Archive) #NC
Closed Won
Q3-2023
​
​
​
​
100
364
9/28/2022
9/29/2021
​
​
Renewal
0015000002IiNnuAAF
​
​
0015000002IiNnuAAF
Submissions; Submissions Archive
Vault
R&D
0015000002IiNnu
​
Cross-doc icon
9/28/2022
US Sales User - R&D SMB
Jim Thai
Calico Life Sciences LLC
Renewal 2022: Calico Life Sciences - Vault Sub/SubA - 10 Subs; 5 SubsA Users
Closed Won
Q3-2023
​
​
​
​
100
142
9/28/2022
5/9/2022
​
Sales
Subscription
0015000001nxYfoAAE
​
​
0015000001nxYfoAAE
​
​
R&D
0015000001nxYfo
​
Cross-doc icon
9/28/2022
US Sales User - R&D ENT
​
Astellas Pharma US LLC
Renewal 2022: Astellas - Issue Management - Active Study License
Closed Won
Q3-2023
​
​
​
​
100
377
9/28/2022
9/16/2021
​
​
Renewal
0015000000IO270AAD
0012J00002N44FaQAJ
0012J00002N44FaQAJ
0012J00002N44FaQAJ
CTMS
Vault
R&D
0015000000IO270
0012J00002bzHrs
Cross-doc icon
9/29/2022
US Sales User - R&D SMB
Jim Thai
Xeris Pharmaceuticals, Inc.
Renewal 2022: Xeris - Submissions and Submissions Archive Renewal
Closed Won
Q3-2023
​
​
​
​
100
364
9/29/2022
10/1/2021
​
​
Renewal
00150000018Qz0AAAS
​
​
00150000018Qz0AAAS
QualityDocs
Vault
R&D
00150000018Qz0A
​
Cross-doc icon
9/29/2022
US Sales User - R&D SMB
Christopher Mundy
Adverum Biotechnologies, Inc.
Renewal 2022: Adverum Biotechnologies - Vault Sub/SubA - 200 ELA
Closed Won
Q3-2023
​
​
​
​
100
364
9/29/2022
10/1/2021
​
​
Renewal
0015000000wO1vGAAS
​
​
0015000000wO1vGAAS
Submissions; Submissions Archive
Vault
R&D
0015000000wO1vG
​
Cross-doc icon
9/29/2022
US Sales User - R&D SMB
Jim Thai
Calico Life Sciences LLC
Renewal 2022: Calico Life Sciences - CTMS - 40 active, 1 archive, 34 future active
Closed Won
Q3-2023
​
​
​
​
100
364
9/29/2022
10/1/2021
​
​
Renewal
0015000001nxYfoAAE
​
​
0015000001nxYfoAAE
eTMF
Vault
R&D
0015000001nxYfo
​
Cross-doc icon
9/29/2022
US Sales User - R&D SMB
Jonathan Waldvogel
Seres Therapeutics, Inc.
Renewal 2022: Seres Therapeutics-Vault RIM, Clinical, & Quality
Closed Won
Q3-2023
​
​
​
​
100
363
9/29/2022
10/1/2021
​
​
Renewal
0015000000zPfrZAAS
​
​
0015000000zPfrZAAS
QualityDocs; Submissions; Submissions Archive
Vault
R&D
0015000000zPfrZ
​
Cross-doc icon
9/29/2022
US Sales User - CRO
Katie Tipton
Social & Scientific Systems, Inc.
Renewal Oct 2022: S3 DMID-BET - Consolidated 61 Sites
Closed Won
Q3-2023
​
​
​
​
100
80
9/29/2022
7/11/2022
​
​
Subscription
0015000000tQUB1AAO
​
​
0015000000tQUB1AAO
​
​
R&D
0015000000tQUB1
​
Cross-doc icon
9/30/2022
US Sales User - R&D SMB
Jim Thai
Xeris Pharmaceuticals, Inc.
Renewal 2022: Xeris - Vault Quality Renewal
Closed Won
Q3-2023
​
​
​
​
100
365
9/30/2022
10/1/2021
​
​
Renewal
00150000018Qz0AAAS
​
​
00150000018Qz0AAAS
QualityDocs
Vault
R&D
00150000018Qz0A
​
Cross-doc icon
9/30/2022
US Sales User - R&D SMB
Phil Sager
Immunocore, Ltd
Renewal 2022: Immunocore - Clinical
Closed Won
Q3-2023
​
​
​
​
100
262
9/30/2022
1/11/2022
​
Sales
Subscription
0012J00002LO4EvQAL
​
​
0012J00002LO4EvQAL
​
​
R&D
0012J00002LO4Ev
​
Cross-doc icon
9/30/2022
EU Sales User - R&D SMB
​
MeiraGTx LLC
Renewal 2022: Meira GTX (New Logo) - eTMF 20 Sites
Closed Won
Q3-2023
​
​
​
​
100
360
9/30/2022
10/5/2021
​
​
Renewal
0012J00002XRL5vQAH
​
​
0012J00002XRL5vQAH
eTMF
Vault
R&D
0012J00002XRL5v
​
Cross-doc icon
10/7/2022
US Sales User - MedTech ENT
​
Becton Dickinson
BD - CTMS & Payments Period 3 Renewal/Superseding final year, eTMF ELA Conversion
6. Awaiting P.O.
Q3-2023
​
​
​
​
99
847
10/7/2022
6/12/2020
​
Strategy Team
Subscription
0012J00002MKF7IQAX
​
​
0012J00002MKF7IQAX
CTMS
Vault
R&D
0012J00002MKF7I
​
Cross-doc icon
10/12/2022
EU Sales User - R&D SMB
​
EUSA Pharma (UK) Ltd
Recordati EUSA Migration 35 sites renewal 3 months
6. Awaiting P.O.
Q3-2023
​
​
​
​
99
46
10/12/2022
8/22/2022
​
​
Subscription
00150000018O5POAA0
0015000000VSdDeAAL
0015000000VSdDeAAL
0015000000VSdDeAAL
​
​
R&D
00150000018O5PO
0015000000VSdDe
Cross-doc icon
10/14/2022
US Sales User - R&D SMB
Jonathan Waldvogel
Surface Oncology Inc.
Renewal 2022: Surface Oncology: Vault Quality Docs & Training
6. Awaiting P.O.
Q3-2023
​
​
​
​
99
350
10/14/2022
10/22/2021
​
Sales
Subscription
00150000018PrBDAA0
​
​
00150000018PrBDAA0
​
​
R&D
00150000018PrBD
​
Cross-doc icon
10/14/2022
US Sales User - R&D SMB
Phil Sager
Roivant Sciences, Inc.
Renewal 2022: Roivant Sciences - LearnGxP
4. Negotiation
Q3-2023
​
​
​
​
90
277
10/14/2022
1/3/2022
​
Sales
Subscription
0015000001APsQwAAL
​
​
0015000001APsQwAAL
​
​
R&D
0015000001APsQw
​
Cross-doc icon
10/14/2022
EU Sales User - R&D SMB
​
MeiraGTx LLC
Renewal 2022 Nov: MeiraGTx (New App) RIM - (Submissions, Archive 10 users)
5. Contracting
Q3-2023
​
​
​
​
99
37
10/14/2022
8/31/2022
​
Marketing
Subscription
0012J00002XRL5vQAH
​
​
0012J00002XRL5vQAH
​
​
R&D
0012J00002XRL5v
​
Cross-doc icon
10/15/2022
US Sales User - R&D SMB
Adam De Oliveira
Ocugen, Inc.
Renewal 2022: Ocugen - QDocs & Training
4. Negotiation
Q3-2023
​
​
​
​
99
37
10/15/2022
8/31/2022
​
Sales Support
Subscription
0015000000tFn6fAAC
​
​
0015000000tFn6fAAC
​
​
R&D
0015000000tFn6f
​
Cross-doc icon
10/15/2022
EU Sales User - R&D SMB
​
RICHTER-HELM BIOLOGICS GMBH & CO. KG
Renewal 2022: Richter-Helm - EU - QMS
6. Awaiting P.O.
Q3-2023
​
​
​
​
99
308
10/15/2022
12/3/2021
​
Sales
Subscription
0015000000ePgYjAAK
​
​
0015000000ePgYjAAK
​
​
R&D
0015000000ePgYj
​
Cross-doc icon
10/17/2022
EU Sales User - R&D ENT
​
Genentech, Inc.
Roche Pharma - QD (EU+US) - Yr 3 renewal
Closed Won
Q3-2023
​
​
​
​
100
739
10/17/2022
10/8/2020
​
Sales
Subscription
0015000000IO27UAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
QualityDocs
Vault
R&D
0015000000IO27U
0015000001nyFxK
Cross-doc icon
10/20/2022
US Sales User - R&D SMB
David Florez
Amneal Pharmaceuticals LLC
Renewal 2022: Amneal - QualityDocs
5. Contracting
Q3-2023
​
​
​
​
99
133
10/20/2022
5/27/2022
​
Sales
Subscription
0015000000LVRnaAAH
0012J00002MKhD2QAL
0012J00002MKhD2QAL
0012J00002MKhD2QAL
​
​
R&D
0015000000LVRna
0012J00002MKhD2
Cross-doc icon
10/21/2022
US Sales User - R&D SMB
Phil Sager
Supernus Pharmaceuticals, Inc.
Renewal 2022: Supernus Pharmaceuticals-QDocs, Training & QMS
4. Negotiation
Q3-2023
​
​
​
​
90
372
10/21/2022
10/1/2021
​
​
Renewal
0015000000PiLnMAAV
​
​
0015000000PiLnMAAV
QMS; QualityDocs
Vault
R&D
0015000000PiLnM
​
Cross-doc icon
10/21/2022
US Manager - R&D Sales
Christopher Mundy
Shattuck Labs, Inc.
Renewal 2022: Shattuck Labs - 100 ELAVault Submissions and 8 Submissions Archive
4. Negotiation
Q3-2023
​
​
​
​
95
351
10/21/2022
10/21/2021
​
Other
Subscription
0012J00002QJUllQAH
​
​
0012J00002QJUllQAH
​
​
R&D
0012J00002QJUll
​
Cross-doc icon
10/21/2022
US Sales User - CRO
Katie Tipton
St. Jude Children's Research Hospital, Inc.
Renewal 2022: St Jude CRH - SiteConnect
5. Contracting
Q3-2023
​
​
​
​
99
236
10/21/2022
2/13/2022
​
Sales
Subscription
00150000014RszdAAC
​
​
00150000014RszdAAC
​
​
R&D
00150000014Rszd
​
Cross-doc icon
10/21/2022
EU Sales User - R&D ENT
​
GSK
Renewal 2022: GSK Vault Platform Health Outcome Tracker
3. Proposal
Q3-2023
​
​
​
​
90
343
10/21/2022
10/29/2021
​
Sales
Subscription
0012J00002LPpFrQAL
​
​
0012J00002LPpFrQAL
​
​
R&D
0012J00002LPpFr
​
Cross-doc icon
10/21/2022
EU Sales User - R&D SMB
​
Oncopeptides AB
Renewal 2022: Oncopeptides- QD, RIM
4. Negotiation
Q3-2023
​
​
​
​
99
246
10/21/2022
2/3/2022
​
Sales
Subscription
0015000001RQkXdAAL
​
​
0015000001RQkXdAAL
​
​
R&D
0015000001RQkXd
​
Cross-doc icon
10/25/2022
LatAm Sales User
​
Laboratorios Sophia, S.A. de C.V.
Renewal 2022: Sophia Mexico eTMF total: 25 Active sites + 1 Archive site
2. Discovery
Q3-2023
​
​
​
​
30
347
10/25/2022
10/25/2021
​
Sales
Subscription
0012J00002LPqbwQAD
​
​
0012J00002LPqbwQAD
​
​
R&D
0012J00002LPqbw
​
Cross-doc icon
10/27/2022
CN Sales User - R&D ENT
​
Suzhou Ceclor Pharmaceutical Co., Ltd.
Renewal 2022: Ceclor-China-QMS-biotech ELA250
5. Contracting
Q3-2023
​
​
​
​
99
345
10/27/2022
10/27/2021
​
Strategy Team
Subscription
0012J00002U7d2UQAR
0015000000tsIxGAAU
0015000000tsIxGAAU
0015000000tsIxGAAU
​
​
R&D
0012J00002U7d2U
0015000000tsIxG
Cross-doc icon
10/31/2022
US Sales User - R&D SMB
Christopher Mundy
Lexicon Pharmaceuticals, Inc
Renewal 2022: Lexicon Submissions, Submissions Archive and Publishing
4. Negotiation
Q3-2023
​
​
​
​
95
319
10/31/2022
11/22/2021
​
Sales
Subscription
0015000000Lq8CgAAJ
​
​
0015000000Lq8CgAAJ
​
​
R&D
0015000000Lq8Cg
​
Cross-doc icon
10/31/2022
US Sales User - R&D SMB
Jonathan Waldvogel
Intarcia Therapeutics, Inc.
Renewal 2022: Intarcia Therapeutics_Veeva QualityDocs Superseding Licensing Extension October 2022
4. Negotiation
Q3-2023
​
​
​
​
95
178
10/31/2022
4/12/2022
​
​
Subscription
0015000001IfBXpAAN
​
​
0015000001IfBXpAAN
​
​
R&D
0015000001IfBXp
​
Cross-doc icon
10/31/2022
JP Sales User - R&D ENT
​
ASAHI KASEI PHARMA CORPORATION
Renewal 2022: Asahikasei Pharma eTMF 32sites - Japan Local Deal
4. Negotiation
Q3-2023
​
​
​
​
90
302
10/31/2022
12/9/2021
​
Sales
Subscription
0015000000ORqreAAD
​
​
0015000000ORqreAAD
​
​
R&D
0015000000ORqre
​
Cross-doc icon
10/31/2022
EU Sales User - CDMS
​
Exom Group Srl
Renewal Dec 2022: Exom - eTMF - 162 sites - dec -feb 3 months
4. Negotiation
Q3-2023
​
​
​
​
95
77
10/31/2022
7/22/2022
​
Sales
Subscription
0015000000tptQnAAI
​
​
0015000000tptQnAAI
​
​
R&D
0015000000tptQn
​
Cross-doc icon
11/1/2022
US Sales User - R&D SMB
Adam De Oliveira
Sanaria
Renewal 2022: Sanaria_Veeva Vault eTMF Renewal
2. Discovery
Q4-2023
​
​
​
​
0
358
11/1/2022
10/14/2021
​
​
Renewal
0015000000mNPPqAAO
​
​
0015000000mNPPqAAO
eTMF
Vault
R&D
0015000000mNPPq
​
Cross-doc icon
11/1/2022
US Sales User - R&D SMB
Adam De Oliveira
Dova Pharmaceuticals, Inc.
Renewal 2022: Dova RIM short term
4. Negotiation
Q4-2023
​
​
​
​
95
340
11/1/2022
11/1/2021
​
Sales
Subscription
0015000001Niyx9AAB
0015000000OU1qNAAT
0015000000OU1qNAAT
0015000000OU1qNAAT
​
​
R&D
0015000001Niyx9
0015000000OU1qN
Cross-doc icon
11/1/2022
US Sales User - R&D SMB
Ernie Chin
Jazz Pharmaceuticals, Inc.
Renewal 2023: Jazz Pharmaceuticals - New Vault - RIM
5. Contracting
Q4-2023
​
​
​
​
98
267
11/1/2022
1/13/2022
​
Sales
Subscription
0015000000IO27gAAD
0012J00002MKw19QAD
0012J00002MKw19QAD
0012J00002MKw19QAD
​
​
R&D
0015000000IO27g
0012J00002bzPP2
Cross-doc icon
11/3/2022
CN Sales User - R&D SMB
​
Mabspace Biosciences (Suzhou) Co. LTd.
Renewal 2022: Mabspacebio-China-QualityDocs-China Biotech ELA 250
4. Negotiation
Q4-2023
​
​
​
​
95
338
11/3/2022
11/3/2021
​
Sales
Subscription
0012J00002Qdd40QAB
0012J00002PxlbbQAB
0012J00002PxlbbQAB
0012J00002PxlbbQAB
​
​
R&D
0012J00002Qdd40
0012J00002Pxlbb
Cross-doc icon
11/4/2022
US Sales User - CDMS
Katie Tipton
Atlantic Research Group, Inc.
Renewal Dec 2022: Atlantic Research Group - CTMS
4. Negotiation
Q4-2023
​
​
​
​
95
46
11/4/2022
8/22/2022
​
Sales
Subscription
0015000000qIWUEAA4
​
​
0015000000qIWUEAA4
​
​
R&D
0015000000qIWUE
​
Cross-doc icon
11/4/2022
US Sales User - CDMS
Katie Tipton
Atlantic Research Group, Inc.
Renewal Dec 2022: Atlantic Research Group eTMF Full Account Renewal 12/1/2022
4. Negotiation
Q4-2023
​
​
​
​
95
46
11/4/2022
8/22/2022
​
​
Subscription
0015000000qIWUEAA4
​
​
0015000000qIWUEAA4
​
​
R&D
0015000000qIWUE
​
Cross-doc icon
11/5/2022
US Sales User - R&D SMB
Jonathan Waldvogel
HilleVax, Inc.
Renewal Dec 2022: HilleVax Submissions and Subs A
5. Contracting
Q4-2023
​
​
​
​
99
127
11/5/2022
6/2/2022
​
Sales
Subscription
0012J00002U6WwuQAF
​
​
0012J00002U6WwuQAF
​
​
R&D
0012J00002U6Wwu
​
Cross-doc icon
11/10/2022
CN Sales User - R&D ENT
​
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Renewal 2022 Dizal-China-eTMF-China Biotech ELA 250
Closed Won
Q4-2023
​
​
​
​
100
716
11/10/2022
11/24/2020
​
​
Renewal
0012J00002RDkCgQAL
0012J00002QK82jQAD
0012J00002QK82jQAD
0012J00002QK82jQAD
eTMF
Vault
R&D
0012J00002RDkCg
0012J00002QK82j
Cross-doc icon
11/11/2022
US Sales User - CRO
Katie Tipton
Social & Scientific Systems, Inc.
Renewal Dec 2022: S3 DMID-BET - Consolidated 61 Sites
4. Negotiation
Q4-2023
​
​
​
​
95
8
11/11/2022
9/29/2022
​
​
Subscription
0015000000tQUB1AAO
​
​
0015000000tQUB1AAO
​
​
R&D
0015000000tQUB1
​
Cross-doc icon
11/15/2022
US Sales User - CRO
Katie Tipton
Technical Resources International, Inc.
Renewal 2022: TRI Vault Subs/Subs A - CCR Vault
4. Negotiation
Q4-2023
​
​
​
​
99
400
11/15/2022
9/2/2021
​
​
Renewal
0015000000olZKlAAM
​
​
0015000000olZKlAAM
Submissions; Submissions Archive
Vault
R&D
0015000000olZKl
​
Cross-doc icon
11/15/2022
US Sales User - R&D SMB
Jim Thai
Turning Point Therapeutics, Inc.
Renewal 2022: Turning Point Therapeutics - Submissions and Submissions Archive
4. Negotiation
Q4-2023
​
​
​
​
80
175
11/15/2022
4/15/2022
​
​
Subscription
0015000001eME6lAAG
​
​
0015000001eME6lAAG
​
​
R&D
0015000001eME6l
​
Cross-doc icon
11/15/2022
US Sales User - CRO
Katie Tipton
Technical Resources International, Inc.
Renewal Dec 2022: TRI eTMF 12-1-2022
4. Negotiation
Q4-2023
​
​
​
​
95
128
11/15/2022
6/1/2022
​
​
Subscription
0015000000olZKlAAM
​
​
0015000000olZKlAAM
​
​
R&D
0015000000olZKl
​
Cross-doc icon
11/16/2022
US Sales User - R&D SMB
Jonathan Waldvogel
Spero Therapeutics, Inc.
Renewal 2022: Spero Therapeutics- QD, VT and QMS ELA 100
5. Contracting
Q4-2023
​
​
​
​
99
322
11/16/2022
11/19/2021
​
Sales
Subscription
0015000001ODHG9AAP
​
​
0015000001ODHG9AAP
​
​
R&D
0015000001ODHG9
​
Cross-doc icon
11/16/2022
US Sales User - R&D SMB
Jonathan Waldvogel
Spero Therapeutics, Inc.
Renewal 2022: Spero Therapeutics- RIM ELA
5. Contracting
Q4-2023
​
​
​
​
99
310
11/16/2022
12/1/2021
​
Sales
Subscription
0015000001ODHG9AAP
​
​
0015000001ODHG9AAP
​
​
R&D
0015000001ODHG9
​
Cross-doc icon
11/17/2022
US Manager - R&D Sales
Christopher Mundy
La Jolla Pharmaceutical Company
Renewal 2022: La Jolla Pharmaceutical Company ? Submissions-eTMF-QualityDocs
4. Negotiation
Q4-2023
​
​
​
​
95
324
11/17/2022
11/17/2021
​
Sales
Subscription
0015000000Lq8CdAAJ
​
​
0015000000Lq8CdAAJ
​
​
R&D
0015000000Lq8Cd
​
Cross-doc icon
11/18/2022
EU Sales User - MedTech ENT
​
Institut Straumann AG
Renewal 2022: Straumann - Vault QMS - period 1 - 8
Closed Won
Q4-2023
​
​
​
​
100
403
11/18/2022
10/11/2021
​
Sales
Subscription
0012J00002U5C7vQAF
​
​
0012J00002U5C7vQAF
QMS
Vault
R&D
0012J00002U5C7v
​
Cross-doc icon
11/23/2022
EU Sales User - R&D SMB
​
Swedish Orphan Biovitrum AB (publ)
Renewal 2023: SOBI RIM
4. Negotiation
Q4-2023
​
​
​
​
95
318
11/23/2022
11/23/2021
​
Sales
Subscription
0015000000OU1qNAAT
​
​
0015000000OU1qNAAT
​
​
R&D
0015000000OU1qN
​
Cross-doc icon
11/24/2022
US Sales User - R&D SMB
Jim Thai
Arcturus Therapeutics, Inc.
Renewal 2022: Arcturus Therapeutics - Vault eTMF - 19 eTMF Active Sites & 2 Archive Sites
3. Proposal
Q4-2023
​
​
​
​
70
317
11/24/2022
11/24/2021
​
Sales
Subscription
0015000000r8H7sAAE
​
​
0015000000r8H7sAAE
​
​
R&D
0015000000r8H7s
​
Cross-doc icon
11/30/2022
US Sales User - R&D SMB
Adam De Oliveira
Acorda Therapeutics, Inc.
Renewal 2022: Acorda Therapeutics - Quality & eTMF
4. Negotiation
Q4-2023
​
​
​
​
99
64
11/30/2022
8/4/2022
​
​
Subscription
0015000000IO26iAAD
​
​
0015000000IO26iAAD
​
​
R&D
0015000000IO26i
​
Cross-doc icon
11/30/2022
EU Sales User - R&D SMB
​
GlaxoSmithKline LLC
Renewal 2023 Jan: GSK Pharma Vault QMS P3
6. Awaiting P.O.
Q4-2023
​
​
​
​
99
687
11/30/2022
11/19/2020
​
Sales
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
QMS
Vault
R&D
0015000000VSniv
0012J00002MJmoR
Cross-doc icon
11/30/2022
EU Sales User - R&D SMB
​
GlaxoSmithKline LLC
Renewal: GSK Consumer Safety 2023
6. Awaiting P.O.
Q4-2023
​
​
​
​
99
666
11/30/2022
12/10/2020
​
Sales
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
Vault Safety
Vault
R&D
0015000000VSniv
0012J00002MJmoR
Cross-doc icon
11/30/2022
EU Sales User - R&D SMB
​
Recordati Rare Diseases, Inc.
Renewal Dec 2022: Recordati US- Vault Training - 153 users
4. Negotiation
Q4-2023
​
​
​
​
95
70
11/30/2022
7/29/2022
​
​
Subscription
0015000000pJSINAA4
0015000000VSdDeAAL
0015000000VSdDeAAL
0015000000VSdDeAAL
​
​
R&D
0015000000pJSIN
0015000000VSdDe
Cross-doc icon
12/1/2022
US Sales User - R&D SMB
Jim Thai
Vaxart, Inc.
Renewal 2023: Vaxart - Vault Sub/SubA - 50 ELA + 5 Archive Users
4. Negotiation
Q4-2023
​
​
​
​
90
399
12/1/2022
9/3/2021
​
​
Renewal
0015000001HesyBAAR
​
​
0015000001HesyBAAR
Submissions; Submissions Archive
Vault
R&D
0015000001HesyB
​
Cross-doc icon
12/1/2022
US Sales User - R&D SMB
Adam De Oliveira
ADC Therapeutics SA
Renewal 2022: ADC Therapeutics - (New Logo) - Submissions Archive
4. Negotiation
Q4-2023
​
​
​
​
95
352
12/1/2022
10/20/2021
​
Sales
Subscription
0015000001CrmGfAAJ
0015000001HhQaiAAF
0015000001HhQaiAAF
0015000001HhQaiAAF
​
​
R&D
0015000001CrmGf
0015000001HhQai
Cross-doc icon
12/1/2022
US Sales User - R&D SMB
Jim Thai
Vaxart, Inc.
Renewal 2023 Jan: Vaxart - Vault QualityDocs/Training - 200 ELA
4. Negotiation
Q4-2023
​
​
​
​
90
340
12/1/2022
11/1/2021
​
Sales
Subscription
0015000001HesyBAAR
​
​
0015000001HesyBAAR
​
​
R&D
0015000001HesyB
​
Cross-doc icon
12/1/2022
US Sales User - R&D SMB
Adam De Oliveira
Iterum Therapeutics International Limited
Renewal 2023: Iterum Therapeutics_Vault eTMF and RIM
4. Negotiation
Q4-2023
​
​
​
​
95
326
12/1/2022
11/15/2021
​
​
Subscription
00150000014TbQlAAK
​
​
00150000014TbQlAAK
​
​
R&D
00150000014TbQl
​
Cross-doc icon
12/1/2022
US Sales User - R&D SMB
Jim Thai
Vaxart, Inc.
Renewal 2022: Vaxart Inc - eTMF - 6 Active Sites, 10 Archive Sites, 26 add-on active sites
4. Negotiation
Q4-2023
​
​
​
​
90
296
12/1/2022
12/15/2021
​
​
Subscription
0015000001HesyBAAR
​
​
0015000001HesyBAAR
​
​
R&D
0015000001HesyB
​
Cross-doc icon
12/1/2022
US Sales User - R&D SMB
Jim Thai
Rigel Pharmaceuticals, Inc.
Renewal 2022: Rigel - QD:37 Full Users, 55 RO Users - VT: 4 Admin Users, 88 Learner Users
4. Negotiation
Q4-2023
​
​
​
​
90
291
12/1/2022
12/20/2021
​
​
Subscription
0015000000NCeXCAA1
​
​
0015000000NCeXCAA1
​
​
R&D
0015000000NCeXC
​
Cross-doc icon
12/1/2022
US Sales User - R&D SMB
Jim Thai
Rigel Pharmaceuticals, Inc.
Renewal 2022: Rigel - eTMF - 223 Active Sites
4. Negotiation
Q4-2023
​
​
​
​
90
291
12/1/2022
12/20/2021
​
Sales
Subscription
0015000000NCeXCAA1
​
​
0015000000NCeXCAA1
​
​
R&D
0015000000NCeXC
​
Cross-doc icon
12/1/2022
US Sales User - R&D SMB
Adam De Oliveira
Neurogene
Renewal 2023: Neurogene_Vault Quality Suite (QualityDocs, Training, QMS)
4. Negotiation
Q4-2023
​
​
​
​
95
221
12/1/2022
2/28/2022
​
​
Subscription
0012J00002IlRrWQAV
​
​
0012J00002IlRrWQAV
​
​
R&D
0012J00002IlRrW
​
Cross-doc icon
12/1/2022
US Sales User - R&D SMB
Adam De Oliveira
Idera Pharmaceuticals, Inc.
Renewal 2022: Idera - Submissions
4. Negotiation
Q4-2023
​
​
​
​
95
219
12/1/2022
3/2/2022
​
Sales
Subscription
0015000000MoUgQAAV
​
​
0015000000MoUgQAAV
​
​
R&D
0015000000MoUgQ
​
Cross-doc icon
12/1/2022
US Sales User - R&D SMB
Jonathan Waldvogel
Cullinan Oncology
Renewal 2023: Cullinan Oncology - Quality Docs/Training
4. Negotiation
Q4-2023
​
​
​
​
95
203
12/1/2022
3/18/2022
​
​
Subscription
0012J00002N4H28QAF
​
​
0012J00002N4H28QAF
​
​
R&D
0012J00002N4H28
​
Cross-doc icon
12/1/2022
US Sales User - R&D SMB
Jonathan Waldvogel
Cullinan Oncology
Renewal 2023: Cullinan Oncology - eTMF - (32)
3. Proposal
Q4-2023
​
​
​
​
40
163
12/1/2022
4/27/2022
​
​
Subscription
0012J00002N4H28QAF
​
​
0012J00002N4H28QAF
​
​
R&D
0012J00002N4H28
​
Cross-doc icon
12/1/2022
US Sales User - R&D SMB
Jim Thai
Sention Therapeutics, LLC
Renewal 2023: Sention Therapeutics - RIM, Quality, & Clinical
5. Contracting
Q4-2023
​
​
​
​
95
161
12/1/2022
4/29/2022
​
Sales
Subscription
0012J00002XV4NEQA1
​
​
0012J00002XV4NEQA1
​
​
R&D
0012J00002XV4NE
​
Cross-doc icon
12/1/2022
US Sales User - R&D SMB
Jim Thai
Intercept Pharmaceuticals, Inc.
Renewal 2023: Intercept - Vault eTMF - 25 Active Sites
5. Contracting
Q4-2023
​
​
​
​
95
151
12/1/2022
5/9/2022
​
Sales
Subscription
0015000000iRqSVAA0
​
​
0015000000iRqSVAA0
​
​
R&D
0015000000iRqSV
​
Cross-doc icon
12/1/2022
EU Sales User - R&D ENT
​
GlaxoSmithKline LLC
Renewal 2023: GSK | SSU 2022
5. Contracting
Q4-2023
​
​
​
​
99
1099
12/1/2022
10/4/2019
​
​
Renewal
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
Study Startup
Vault
R&D
0015000000VSniv
0012J00002MJmoR
Cross-doc icon
12/1/2022
EU Sales User - R&D SMB
​
Ferring Pharmaceuticals A/S
Renewal 2023: Ferring - Vault CTMS/SSU/Payments
5. Contracting
Q4-2023
​
​
​
​
98
331
12/1/2022
11/10/2021
​
​
Subscription
0012J00002N5k6lQAB
0012J00002MKF7XQAX
0012J00002MKF7XQAX
0012J00002MKF7XQAX
​
​
R&D
0012J00002N5k6l
0012J00002MKF7X
Cross-doc icon
12/1/2022
US Sales User - Safety
​
SCTbio a.s.
Renewal 2022: SOTIO A.S. - QDocs ELA 100 + QMS ELA 100
4. Negotiation
Q4-2023
​
​
​
​
95
310
12/1/2022
12/1/2021
​
Other
Subscription
0015000000ePOfRAAW
​
​
0015000000ePOfRAAW
​
​
R&D
0015000000ePOfR
​
Cross-doc icon
12/1/2022
EU Sales User - R&D ENT
​
F. HOFFMANN-LA ROCHE AG
Renewal 2023: Roche Diagnostics SRT - 235 Licenses
5. Contracting
Q4-2023
​
​
​
​
99
303
12/1/2022
12/8/2021
​
​
Subscription
0015000000aQSXBAA4
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
​
​
R&D
0015000000aQSXB
0012J00002MJstk
Cross-doc icon
12/1/2022
EU Sales User - R&D ENT
​
GlaxoSmithKline LLC
Renewal 2022: GSK Biopharma eTMF ELA
6. Awaiting P.O.
Q4-2023
​
​
​
​
99
295
12/1/2022
12/16/2021
​
Sales
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
​
​
R&D
0015000000VSniv
0012J00002MJmoR
Cross-doc icon
12/1/2022
EU Sales User - R&D ENT
​
GlaxoSmithKline LLC
Renewal 2022: GSK Biopharma CTMS ELA
6. Awaiting P.O.
Q4-2023
​
​
​
​
99
295
12/1/2022
12/16/2021
​
Sales
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
​
​
R&D
0015000000VSniv
0012J00002MJmoR
Cross-doc icon
12/1/2022
EU Sales User - R&D ENT
​
J&J Pharmaceuticals
Renewal 2023: Johnson & Johnson QualityDocs EU
4. Negotiation
Q4-2023
​
​
​
​
95
288
12/1/2022
12/23/2021
​
Sales
Subscription
0012J00002MJmrHQAT
0015000001RO8AFAA1
0015000001RO8AFAA1
0015000001RO8AFAA1
​
​
R&D
0012J00002MJmrH
0015000001RO8AF
Cross-doc icon
12/1/2022
EU Sales User - R&D SMB
​
Recordati Rare Diseases Sarl
Renewal 2022 Dec: Renewal-Recordati Rare Diseases FR- eTMF 2021
4. Negotiation
Q4-2023
​
​
​
​
99
248
12/1/2022
2/1/2022
​
Sales
Subscription
0012J00002ZZKmtQAH
0015000000VSdDeAAL
0015000000VSdDeAAL
0015000000VSdDeAAL
​
​
R&D
0012J00002ZZKmt
0015000000VSdDe
Cross-doc icon
12/1/2022
US Sales User - Safety
​
SOTIO Biotech a.s.
Renewal 2022: SOTIO Biotech - QDocs ELA 200 / QMS ELA 200
4. Negotiation
Q4-2023
​
​
​
​
95
219
12/1/2022
3/2/2022
​
Sales
Subscription
0012J00002X2YJBQA3
0015000000ePOfRAAW
0015000000ePOfRAAW
0015000000ePOfRAAW
​
​
R&D
0012J00002X2YJB
0015000000ePOfR
Cross-doc icon
12/1/2022
EU Sales User - R&D ENT
​
GlaxoSmithKline Biologicals SA
Renewal 2023: GSK Vaccines Vault Platform Reg Intel QRI 2021
5. Contracting
Q4-2023
​
​
​
​
99
203
12/1/2022
3/18/2022
​
​
Subscription
0015000000iVjitAAC
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
​
​
R&D
0015000000iVjit
0012J00002MJmoR
Cross-doc icon
12/1/2022
EU Sales User - R&D ENT
​
UCB Biopharma SRL
Renewal Jan 2023: UCB Zogenix Legacy eTMF - $0 OF For migration
4. Negotiation
Q4-2023
​
​
​
​
95
35
12/1/2022
9/2/2022
​
Sales
Subscription
00150000018OaEYAA0
0012J00002MJ2bHQAT
0012J00002MJ2bHQAT
0012J00002MJ2bHQAT
​
​
R&D
00150000018OaEY
0012J00002bzOpx
Cross-doc icon
12/1/2022
US Sales User - R&D ENT
​
MSD Pharmaceuticals
Renewal 2023: Merck_Vault eTMF_
5. Contracting
Q4-2023
​
​
​
​
99
297
12/1/2022
12/14/2021
​
Sales
Subscription
0012J00002MJsusQAD
0012J00002LPcIzQAL
0012J00002LPcIzQAL
0012J00002LPcIzQAL
​
​
R&D
0012J00002MJsus
0012J00002LPcIz
Cross-doc icon
12/1/2022
US Sales User - R&D SMB
​
J&J Pharmaceuticals
Renewal 2023: Johnson & Johnson QualityDocs - US split
4. Negotiation
Q4-2023
​
​
​
​
95
265
12/1/2022
1/15/2022
​
Sales
Subscription
0012J00002MJmrHQAT
0015000001RO8AFAA1
0015000001RO8AFAA1
0015000001RO8AFAA1
​
​
R&D
0012J00002MJmrH
0015000001RO8AF
Cross-doc icon
12/1/2022
US Sales User - Commercial ENT
​
Elanco US Inc.
Renewal 2023: Elanco - CTMS + eTMF ELA
4. Negotiation
Q4-2023
​
​
​
​
95
310
12/1/2022
12/1/2021
​
Sales
Subscription
0015000000KQOA1AAP
0012J00002MKyheQAD
0012J00002MKyheQAD
0012J00002MKyheQAD
​
​
R&D
0015000000KQOA1
0012J00002MKyhe
Cross-doc icon
12/1/2022
US Sales User - MedTech ENT
​
Boston Scientific Corporation
Renewal 2022: Boston Scientific - QMS
5. Contracting
Q4-2023
​
​
​
​
99
318
12/1/2022
11/23/2021
​
Sales
Subscription
0015000000LVRzoAAH
0012J00002MKhDCQA1
0012J00002MKhDCQA1
0012J00002MKhDCQA1
​
​
R&D
0015000000LVRzo
0012J00002MKhDC
Cross-doc icon
12/2/2022
US Sales User - MedTech ENT
​
Abbott MedTech
Renewal 2022: Abbott Diabetes Care - NA - eTMF - 230ELA
5. Contracting
Q4-2023
​
​
​
​
99
309
12/2/2022
12/2/2021
​
​
Subscription
0012J00002ZERRwQAP
0012J00002MK4X8QAL
0012J00002MK4X8QAL
0012J00002MK4X8QAL
​
​
R&D
0012J00002ZERRw
0012J00002MK4X8
Cross-doc icon
12/2/2022
US Sales User - R&D ENT
​
MSD Pharmaceuticals
Renewal 2022: Merck - QMS MRL
6. Awaiting P.O.
Q4-2023
​
​
​
​
99
309
12/2/2022
12/2/2021
​
Sales
Subscription
0012J00002MJsusQAD
0012J00002LPcIzQAL
0012J00002LPcIzQAL
0012J00002LPcIzQAL
​
​
R&D
0012J00002MJsus
0012J00002LPcIz
Cross-doc icon
12/3/2022
EU Sales User - R&D ENT
​
Roche Diagnostics GmbH
Renewal 2022: Roche DIA - Veeva eConsent
2. Discovery
Q4-2023
​
​
​
​
20
308
12/3/2022
12/3/2021
​
Sales
Subscription
0015000000pJthCAAS
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
​
​
R&D
0015000000pJthC
0012J00002MJsuJ
Cross-doc icon
12/7/2022
EU Sales User - R&D ENT
​
UCB Biopharma SRL
Renewal 2022: UCB - NextGen ECMS - SubmissionsArchive 20 users
4. Negotiation
Q4-2023
​
​
​
​
95
304
12/7/2022
12/7/2021
​
Sales
Subscription
00150000018OaEYAA0
0012J00002MJ2bHQAT
0012J00002MJ2bHQAT
0012J00002MJ2bHQAT
​
​
R&D
00150000018OaEY
0012J00002bzOpx
Cross-doc icon
12/7/2022
US Sales User - R&D ENT
​
MSD Pharmaceuticals
Renewal 2022: Merck_RA HH_RIM Suite_Year 6 Renewal
5. Contracting
Q4-2023
​
​
​
​
99
304
12/7/2022
12/7/2021
​
Sales
Subscription
0012J00002MJsusQAD
0012J00002LPcIzQAL
0012J00002LPcIzQAL
0012J00002LPcIzQAL
​
​
R&D
0012J00002MJsus
0012J00002LPcIz
Cross-doc icon
12/9/2022
EU Sales User - CDMS
​
Health Data Specialists S.A.
Renewal 2023: HeadsCRO - eTMF - 32 sites
4. Negotiation
Q4-2023
​
​
​
​
95
302
12/9/2022
12/9/2021
​
Sales
Subscription
0015000002IigC0AAJ
​
​
0015000002IigC0AAJ
​
​
R&D
0015000002IigC0
​
Cross-doc icon
12/10/2022
EU Sales User - R&D ENT
​
Roche Diagnostics GmbH
Renewal 2023: Roche Diagnostics eTMF ELA
5. Contracting
Q4-2023
​
​
​
​
99
330
12/10/2022
11/11/2021
​
​
Subscription
0015000000pJthCAAS
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
​
​
R&D
0015000000pJthC
0012J00002MJsuJ
Cross-doc icon
12/10/2022
EU Sales User - R&D ENT
​
Roche Diabetes Care GmbH
Renewal 2023: Roche Diabetes Care CTMS, SSU, Payments
3. Proposal
Q4-2023
​
​
​
​
90
270
12/10/2022
1/10/2022
​
​
Subscription
00150000019uxEyAAI
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
​
​
R&D
00150000019uxEy
0012J00002MJstk
Cross-doc icon
12/13/2022
EU Sales User - R&D ENT
​
F. Hoffmann-La Roche Ltd
Renewal 2023: Roche HTAg 1000 RO and 150 FU (EU&US)
6. Awaiting P.O.
Q4-2023
​
​
​
​
99
298
12/13/2022
12/13/2021
​
​
Subscription
0015000000VSdHgAAL
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
​
​
R&D
0015000000VSdHg
0012J00002MJstk
Cross-doc icon
12/14/2022
US Sales User - MedTech ENT
​
Cerus Corporation
Renewal 2023: Cerus Corporation - QMS ELA400
4. Negotiation
Q4-2023
​
​
​
​
95
297
12/14/2022
12/14/2021
​
Sales
Subscription
0015000000Lq8BBAAZ
​
​
0015000000Lq8BBAAZ
​
​
R&D
0015000000Lq8BB
​
Cross-doc icon
12/14/2022
EU Sales User - R&D SMB
​
GlaxoSmithKline LLC
Renewal 2022: GSK Biopharma RIM ELA
4. Negotiation
Q4-2023
​
​
​
​
95
297
12/14/2022
12/14/2021
​
Sales
Subscription
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
​
​
R&D
0015000000VSniv
0012J00002MJmoR
Cross-doc icon
12/14/2022
EU Sales User - R&D SMB
​
EUSA Pharma (UK) Ltd
Renewal 2022: EUSA Pharma (UK) Ltd - Vault QMS and QualityDocs - ELA 400
4. Negotiation
Q4-2023
​
​
​
​
95
297
12/14/2022
12/14/2021
​
Sales
Subscription
00150000018O5POAA0
0015000000VSdDeAAL
0015000000VSdDeAAL
0015000000VSdDeAAL
​
​
R&D
00150000018O5PO
0015000000VSdDe
Cross-doc icon
12/14/2022
US Sales User - R&D SMB
Ernie Chin
American Regent, Inc.
Renewal 2023: American Regent _QDocs ELA
6. Awaiting P.O.
Q4-2023
​
​
​
​
99
297
12/14/2022
12/14/2021
​
Sales
Subscription
0015000000IO26vAAD
0012J00002MK4XEQA1
0012J00002MK4XEQA1
0012J00002MK4XEQA1
​
​
R&D
0015000000IO26v
0012J00002bzOnv
Cross-doc icon
12/15/2022
US Sales User - R&D SMB
Christopher Mundy
Endpoint Health Inc.
Renewal 2023: Endpoint Health - Vault eTMF/CTMS - 25 Site Count
3. Proposal
Q4-2023
​
​
​
​
95
296
12/15/2022
12/15/2021
​
Sales
Subscription
0012J00002ZExxBQAT
​
​
0012J00002ZExxBQAT
​
​
R&D
0012J00002ZExxB
​
Cross-doc icon
12/15/2022
US Sales User - R&D SMB
Adam De Oliveira
Luye Pharma (USA), Ltd
Renewal 2023: Luye - Vault Publishing
2. Discovery
Q4-2023
​
​
​
​
30
262
12/15/2022
1/18/2022
​
​
Subscription
0015000001MbT4CAAV
00150000025cbFjAAI
00150000025cbFjAAI
00150000025cbFjAAI
​
​
R&D
0015000001MbT4C
00150000025cbFj
Cross-doc icon
12/15/2022
US Sales User - R&D SMB
Adam De Oliveira
Luye Pharma (USA), Ltd
Renewal 2023: Luye Pharma - US - Submissions
4. Negotiation
Q4-2023
​
​
​
​
95
262
12/15/2022
1/18/2022
​
​
Subscription
0015000001MbT4CAAV
00150000025cbFjAAI
00150000025cbFjAAI
00150000025cbFjAAI
​
​
R&D
0015000001MbT4C
00150000025cbFj
Cross-doc icon
12/15/2022
US Sales User - R&D SMB
​
J&J Pharmaceuticals
Renewal Jan 2023: Momenta RIM, QD, QMS, Training ELA200
4. Negotiation
Q4-2023
​
​
​
​
99
79
12/15/2022
7/20/2022
​
​
Subscription
0012J00002MJmrHQAT
0015000001RO8AFAA1
0015000001RO8AFAA1
0015000001RO8AFAA1
​
​
R&D
0012J00002MJmrH
0015000001RO8AF
Cross-doc icon
12/16/2022
US Sales User - R&D SMB
Jim Thai
Neurelis, Inc.
Renewal 2022: Neurelis - Vault QualityDocs and Vault Training - 200 ELA
4. Negotiation
Q4-2023
​
​
​
​
95
295
12/16/2022
12/16/2021
​
​
Subscription
0015000002IjF01AAF
​
​
0015000002IjF01AAF
​
​
R&D
0015000002IjF01
​
Cross-doc icon
12/16/2022
EU Sales User - R&D SMB
​
Recordati S.P.A.
Renewal 2022: Recordati - Vault Development Cloud December
4. Negotiation
Q4-2023
​
​
​
​
95
254
12/16/2022
1/26/2022
​
Sales
Subscription
0015000000VSdDeAAL
​
​
0015000000VSdDeAAL
​
​
R&D
0015000000VSdDe
​
Cross-doc icon
12/16/2022
LatAm Manager - Sales
​
Cellera Famacêutica S/A
Renewal 2022: Cellera Brazil Submissions 8 Users + Base
4. Negotiation
Q4-2023
​
​
​
​
95
295
12/16/2022
12/16/2021
​
Sales
Subscription
0012J00002J2vsZQAR
​
​
0012J00002J2vsZQAR
​
​
R&D
0012J00002J2vsZ
​
Cross-doc icon
12/17/2022
US Sales User - R&D SMB
​
International AIDS Vaccine Initiative, Inc.
Renewal 2023: IAVI- eTMF 4 Archive Sites Mult-Year T002 Trial
Closed Won
Q4-2023
​
​
​
​
100
712
12/17/2022
1/4/2021
​
​
Renewal
00150000019DKfQAAW
​
​
00150000019DKfQAAW
eTMF
Vault
R&D
00150000019DKfQ
​
Cross-doc icon
12/17/2022
EU Sales User - R&D ENT
​
Sanofi Aventis Groupe
RENEWAL: 2023 Sanofi - eTMF ELA Yr 4 - US&EU
5. Contracting
Q4-2023
​
​
​
​
90
1247
12/17/2022
5/9/2019
​
​
Renewal
0015000000Kjce7AAB
0015000001TVjdfAAD
0015000001TVjdfAAD
0015000001TVjdfAAD
eTMF
Vault
R&D
0015000000Kjce7
0012J00002bz91p
Cross-doc icon
12/17/2022
EU Sales User - R&D ENT
​
GlaxoSmithKline LLC
GSK Pharma Payments P3 Renewal
Closed Won
Q4-2023
​
​
​
​
100
871
12/17/2022
7/29/2020
​
​
Renewal
0015000000VSnivAAD
0012J00002LPpFrQAL
0012J00002LPpFrQAL
0012J00002LPpFrQAL
Payments
Vault
R&D
0015000000VSniv
0012J00002MJmoR
Cross-doc icon
12/17/2022
EU Sales User - R&D ENT
​
UCB Biopharma SRL
Renewal 2023: UCB - Trackwise replacement - QMS & QD ELA Y3
Closed Won
Q4-2023
​
​
​
​
100
754
12/17/2022
11/23/2020
​
Sales
Renewal
00150000018OaEYAA0
0012J00002MJ2bHQAT
0012J00002MJ2bHQAT
0012J00002MJ2bHQAT
QMS; QualityDocs
Vault
R&D
00150000018OaEY
0012J00002bzOpx
Cross-doc icon
12/17/2022
EU Sales User - R&D ENT
​
J&J Pharmaceuticals
Renewal 2023: Janssen - Vault Platform - Grants Management - 60 FU 70 RO - Global
4. Negotiation
Q4-2023
​
​
​
​
90
249
12/17/2022
1/31/2022
​
Sales
Subscription
0012J00002MJmrHQAT
0015000001RO8AFAA1
0015000001RO8AFAA1
0015000001RO8AFAA1
​
​
R&D
0012J00002MJmrH
0015000001RO8AF
Cross-doc icon
12/17/2022
US Sales User - R&D ENT
​
Roche Diagnostics Operations, Inc
Renewal 2023: Roche Diagnostics - Vault QMS Audit - EU&US
5. Contracting
Q4-2023
​
​
​
​
99
316
12/17/2022
11/25/2021
​
Sales
Subscription
0015000000LXz5MAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
​
​
R&D
0015000000LXz5M
0012J00002MJsuJ
Cross-doc icon
12/17/2022
US Sales User - R&D ENT
​
Roche Diagnostics Operations, Inc
Renewal 2023: Roche Diagnostics - RIM - EU/US Renewal
4. Negotiation
Q4-2023
​
​
​
​
99
309
12/17/2022
12/2/2021
​
Sales
Subscription
0015000000LXz5MAAT
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
​
​
R&D
0015000000LXz5M
0012J00002MJsuJ
Cross-doc icon
12/18/2022
US Sales User - R&D SMB
Jim Thai
Intercept Pharmaceuticals, Inc.
Renewal 2023: Intercept - Vault Submissions ELA, SubsA 10 users, Registrations 20 users
5. Contracting
Q4-2023
​
​
​
​
95
293
12/18/2022
12/18/2021
​
Sales
Subscription
0015000000iRqSVAA0
​
​
0015000000iRqSVAA0
​
​
R&D
0015000000iRqSV
​
Cross-doc icon
12/18/2022
US Sales User - R&D SMB
Phil Sager
TG Therapeutics, Inc.
Renewal 2023: TG Therapeutics - Submissions Archive - 19 Users
1. Prospecting
Q4-2023
​
​
​
​
10
293
12/18/2022
12/18/2021
​
Sales
Subscription
0015000000dbgxqAAA
​
​
0015000000dbgxqAAA
​
​
R&D
0015000000dbgxq
​
Cross-doc icon
12/18/2022
EU Sales User - R&D ENT
​
UCB Biopharma SRL
Renewal 2023 UCB Submission,eTMF,Registrations ELA superseding Y3
Closed Won
Q4-2023
​
​
​
​
100
755
12/18/2022
11/23/2020
​
Sales
Renewal
00150000018OaEYAA0
0012J00002MJ2bHQAT
0012J00002MJ2bHQAT
0012J00002MJ2bHQAT
eTMF; Registrations; Submissions
Vault
R&D
00150000018OaEY
0012J00002bzOpx
Cross-doc icon
12/21/2022
US Sales User - R&D SMB
Adam De Oliveira
Kadmon Pharmaceuticals, LLC
Renewal 2023: Kadmon Multi-Vault
4. Negotiation
Q4-2023
​
​
​
​
95
290
12/21/2022
12/21/2021
​
​
Subscription
0015000000YHQeAAAX
0015000001TVjdfAAD
0015000001TVjdfAAD
0015000001TVjdfAAD
​
​
R&D
0015000000YHQeA
0015000001TVjdf
Cross-doc icon
12/21/2022
US Sales User - R&D ENT
​
Acceleron Pharma Inc.
Renewal 2022: Acceleron- Submissions
4. Negotiation
Q4-2023
​
​
​
​
80
290
12/21/2022
12/21/2021
​
Sales
Subscription
0015000000Lq8AVAAZ
0012J00002LPcIzQAL
0012J00002LPcIzQAL
0012J00002LPcIzQAL
​
​
R&D
0015000000Lq8AV
0012J00002LPcIz
Cross-doc icon
12/21/2022
EU Sales User - R&D ENT
​
Sanofi Aventis Groupe
Renewal 2023: Sanofi - Vault RIM (Reg,Sub,SubA) ELA Renewal
5. Contracting
Q4-2023
​
​
​
​
99
290
12/21/2022
12/21/2021
​
Sales
Subscription
0015000000Kjce7AAB
0015000001TVjdfAAD
0015000001TVjdfAAD
0015000001TVjdfAAD
​
​
R&D
0015000000Kjce7
0012J00002bz91p
Cross-doc icon
12/22/2022
US Sales User - MedTech ENT
​
Cerus Corporation
Renewal 2022: Cerus Corporation - eTMF Active Sites
4. Negotiation
Q4-2023
​
​
​
​
99
289
12/22/2022
12/22/2021
​
​
Subscription
0015000000Lq8BBAAZ
​
​
0015000000Lq8BBAAZ
​
​
R&D
0015000000Lq8BB
​
Cross-doc icon
12/22/2022
US Sales User - R&D ENT
​
Takeda Pharmaceuticals U.S.A., Inc.
Renewal: Takeda- QualityDocs - Global - Year 3
Closed Won
Q4-2023
​
​
​
​
100
854
12/22/2022
8/20/2020
​
Sales
Subscription
0015000000IO28HAAT
0012J00002LPydAQAT
0012J00002LPydAQAT
0012J00002LPydAQAT
QualityDocs
Vault
R&D
0015000000IO28H
0012J00002MJsv2
Cross-doc icon
12/26/2022
US Sales User - CRO
​
InVentiv Health Clinical, LLC, a subsidiary of Syneos Health Inc
Renewal Jan 2023: Haleon (GSK CH) 300025 - SH 7035155
4. Negotiation
Q4-2023
​
​
​
​
95
11
12/26/2022
9/26/2022
​
Sales
Subscription
0012J00002KlvT8QAJ
0012J00002MKPWbQAP
0012J00002MKPWbQAP
0012J00002MKPWbQAP
​
​
R&D
0012J00002KlvT8
0012J00002MKPWb
Cross-doc icon
12/30/2022
US Sales User - R&D SMB
Phil Sager
Supernus Pharmaceuticals, Inc.
Renewal 2023: Supernus - LearnGxP - annual training material
4. Negotiation
Q4-2023
​
​
​
​
95
247
12/30/2022
2/2/2022
​
Sales
Subscription
0015000000PiLnMAAV
​
​
0015000000PiLnMAAV
​
​
R&D
0015000000PiLnM
​
Cross-doc icon
12/31/2022
US Sales User - R&D SMB
Jim Thai
Nektar Therapeutics
2023 Renewal: Nektar Therapeutics - QMS ELA
5. Contracting
Q4-2023
​
​
​
​
95
45
12/31/2022
8/23/2022
​
Sales
Subscription
0015000000Lq8D5AAJ
0012J00002PUIc1QAH
0012J00002PUIc1QAH
0012J00002PUIc1QAH
​
​
R&D
0015000000Lq8D5
0012J00002PUIc1
Cross-doc icon
12/31/2022
EU Manager - R&D Sales
​
Zambon S.p.A.
Renewal 2023: Zambon - Vault RIM & eTMF
5. Contracting
Q4-2023
​
​
​
​
99
290
12/31/2022
12/21/2021
​
Sales
Subscription
0015000000OgSzlAAF
​
​
0015000000OgSzlAAF
​
​
R&D
0015000000OgSzl
​
Cross-doc icon
1/1/2023
US Sales User - R&D SMB
Adam De Oliveira
TherapeuticsMD, Inc.
Renewal 2023: TherapeuticsMD New SubmissionsArchive
2. Discovery
Q4-2023
​
​
​
​
80
373
1/1/2023
9/29/2021
​
​
Renewal
0015000000dbU1sAAE
​
​
0015000000dbU1sAAE
Submissions Archive
Vault
R&D
0015000000dbU1s
​
Cross-doc icon
1/1/2023
US Sales User - MedTech ENT
​
Insulet Corporation
Renewal 2023: Insulet- RIM
5. Contracting
Q4-2023
​
​
​
​
98
322
1/1/2023
11/19/2021
​
Sales
Subscription
0015000000OfTIYAA3
​
​
0015000000OfTIYAA3
​
​
R&D
0015000000OfTIY
​
Cross-doc icon
1/1/2023
US Sales User - R&D SMB
Jim Thai
Assembly Biosciences, Inc.
Renewal 2023: Assembly Biosciences - Vault Subs/SubsA, QDocs, Training, & eTMF/eTMF Archive
4. Negotiation
Q4-2023
​
​
​
​
95
259
1/1/2023
1/21/2022
​
​
Subscription
0015000001MbWOaAAN
​
​
0015000001MbWOaAAN
​
​
R&D
0015000001MbWOa
​
Cross-doc icon
1/1/2023
US Sales User - R&D SMB
Adam De Oliveira
Neurogene
Renewal 2023: Neurogene_Vault RIM (Submissions/Submissions Archive)
4. Negotiation
Q4-2023
​
​
​
​
95
256
1/1/2023
1/24/2022
​
Sales
Subscription
0012J00002IlRrWQAV
​
​
0012J00002IlRrWQAV
​
​
R&D
0012J00002IlRrW
​
Cross-doc icon
1/1/2023
US Sales User - CRO
Katie Tipton
Paragon Bioteck, Inc.
Renewal 2023: Paragon Bioteck, Vault Submissions and SubmissionsArchive
4. Negotiation
Q4-2023
​
​
​
​
90
137
1/1/2023
5/23/2022
​
​
Subscription
0015000001KNAOJAA5
0015000001Dqpq2AAB
0015000001Dqpq2AAB
0015000001Dqpq2AAB
​
​
R&D
0015000001KNAOJ
0015000001Dqpq2
Cross-doc icon
1/1/2023
US Sales User - MedTech ENT
​
Roche MedTech
Renewal 2023: FMI QMS ELA & QDocs ELA
5. Contracting
Q4-2023
​
​
​
​
99
31
1/1/2023
9/6/2022
​
Sales
Subscription
0012J00002ZERRvQAP
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
​
​
R&D
0012J00002ZERRv
0015000001nyFxK
Cross-doc icon
1/1/2023
US Sales User - MedTech ENT
​
Roche MedTech
Renewal 2023: FMI - Companion Study Model CTMS / eTMF
5. Contracting
Q4-2023
​
​
​
​
99
30
1/1/2023
9/7/2022
​
Sales
Subscription
0012J00002ZERRvQAP
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
​
​
R&D
0012J00002ZERRv
0015000001nyFxK
Cross-doc icon
1/1/2023
Asia Pac Sales User - R&D ENT
​
MEDYTOX
Renewal 2023: Medytox eTMF 32 Active sites renewal
2. Discovery
Q4-2023
​
​
​
​
80
240
1/1/2023
2/9/2022
​
​
Subscription
0015000001KNJtiAAH
​
​
0015000001KNJtiAAH
​
​
R&D
0015000001KNJti
​
Cross-doc icon
1/1/2023
US Sales User - MedTech ENT
​
Boston Scientific Corporation
Boston Scientific eTMF/CTMS- Year 3 Renewal of ELA
6. Awaiting P.O.
Q4-2023
​
​
​
​
99
1285
1/1/2023
4/1/2019
​
Sales
Subscription
0015000000LVRzoAAH
0012J00002MKhDCQA1
0012J00002MKhDCQA1
0012J00002MKhDCQA1
eTMF
Vault
R&D
0015000000LVRzo
0012J00002MKhDC
Cross-doc icon
1/4/2023
US Sales User - R&D SMB
Phil Sager
Urovant Sciences, Inc.
Renewal 2023: Urovant (SV) - Vault QualityDocs & Training ELA200
4. Negotiation
Q4-2023
​
​
​
​
95
276
1/4/2023
1/4/2022
​
Sales
Subscription
0015000001RO2Q4AAL
0012J00002MKw1cQAD
0012J00002MKw1cQAD
0012J00002MKw1cQAD
​
​
R&D
0015000001RO2Q4
0012J00002OfD5X
Cross-doc icon
1/5/2023
US Sales User - R&D SMB
Jonathan Waldvogel
Kiniksa Pharmaceuticals Corp.
Renewal 2023: Kiniksa Pharmaceuticals- QualityDocs, Training and QMS
4. Negotiation
Q4-2023
​
​
​
​
95
275
1/5/2023
1/5/2022
​
​
Subscription
0015000001HfFYcAAN
​
​
0015000001HfFYcAAN
​
​
R&D
0015000001HfFYc
​
Cross-doc icon
1/6/2023
US Sales User - R&D SMB
Phil Sager
Immunocore, Ltd
Renewal 2023: Immunocore_Vault CTMS
4. Negotiation
Q4-2023
​
​
​
​
95
274
1/6/2023
1/6/2022
​
Sales
Subscription
0012J00002LO4EvQAL
​
​
0012J00002LO4EvQAL
​
​
R&D
0012J00002LO4Ev
​
Cross-doc icon
1/6/2023
EU Sales User - R&D SMB
​
Cycle Pharmaceuticals Ltd.
Renewal 2023: Cycle Pharmaceuticals Ltd. - Vault Submissions & Submissions Archive
4. Negotiation
Q4-2023
​
​
​
​
95
274
1/6/2023
1/6/2022
​
Sales
Subscription
00150000019CzsZAAS
​
​
00150000019CzsZAAS
​
​
R&D
00150000019CzsZ
​
Cross-doc icon
1/6/2023
EU Sales User - R&D SMB
​
Trizell Ltd
Renewal 2023: Trizell - Submissions 20 users
4. Negotiation
Q4-2023
​
​
​
​
95
274
1/6/2023
1/6/2022
​
​
Subscription
0015000001MaFTKAA3
​
​
0015000001MaFTKAA3
​
​
R&D
0015000001MaFTK
​
Cross-doc icon
1/6/2023
US Sales User - R&D ENT
​
MSD Pharmaceuticals
Renewal 2023: Merck_Vault QualityDocs - ELA Conversion Steady State Renewal 2022
6. Awaiting P.O.
Q4-2023
​
​
​
​
99
274
1/6/2023
1/6/2022
​
​
Subscription
0012J00002MJsusQAD
0012J00002LPcIzQAL
0012J00002LPcIzQAL
0012J00002LPcIzQAL
​
​
R&D
0012J00002MJsus
0012J00002LPcIz
Cross-doc icon
1/8/2023
US Sales User - CRO
​
InVentiv Health Clinical, LLC, a subsidiary of Syneos Health Inc
Renewal Feb 2023: Haleon (GSK CH) 300024 / SH 7035173
4. Negotiation
Q4-2023
​
​
​
​
95
46
1/8/2023
8/22/2022
​
Sales
Subscription
0012J00002KlvT8QAJ
0012J00002MKPWbQAP
0012J00002MKPWbQAP
0012J00002MKPWbQAP
​
​
R&D
0012J00002KlvT8
0012J00002MKPWb
Cross-doc icon
1/11/2023
US Sales User - R&D SMB
Ernie Chin
Amarin Corporation
Renewal 2023: Amarin QDOCS
5. Contracting
Q4-2023
​
​
​
​
98
269
1/11/2023
1/11/2022
​
Sales
Subscription
0015000000MMajDAAT
​
​
0015000000MMajDAAT
​
​
R&D
0015000000MMajD
​
Cross-doc icon
1/12/2023
US Sales User - R&D SMB
Adam De Oliveira
BioXcel Therapeutics, Inc.
Renewal 2023: BioXcel - QualityDocs/Training ELA200 & RIM
4. Negotiation
Q4-2023
​
​
​
​
95
291
1/12/2023
12/20/2021
​
​
Subscription
0015000002Ijr2RAAR
​
​
0015000002Ijr2RAAR
​
​
R&D
0015000002Ijr2R
​
Cross-doc icon
1/12/2023
US Sales User - R&D SMB
Phil Sager
Myovant Sciences, Inc.
Renewal 2023: Myovant Sciences - Vault QualityDocs & Training
4. Negotiation
Q4-2023
​
​
​
​
95
268
1/12/2023
1/12/2022
​
Sales
Subscription
0015000001OFSfGAAX
0012J00002MKw1cQAD
0012J00002MKw1cQAD
0012J00002MKw1cQAD
​
​
R&D
0015000001OFSfG
0012J00002OfD5X
Cross-doc icon
1/12/2023
US Sales User - R&D SMB
Adam De Oliveira
BioXcel Therapeutics, Inc.
Renewal 2023: BioXcel Therapeutics - QMS - 25 users
4. Negotiation
Q4-2023
​
​
​
​
95
262
1/12/2023
1/18/2022
​
Sales
Subscription
0015000002Ijr2RAAR
​
​
0015000002Ijr2RAAR
​
​
R&D
0015000002Ijr2R
​
Cross-doc icon
1/12/2023
US Sales User - R&D SMB
Adam De Oliveira
BioXcel Therapeutics, Inc.
Renewal 2023: BioXcel_LearnGxP_ELA 200
4. Negotiation
Q4-2023
​
​
​
​
95
170
1/12/2023
4/20/2022
​
Sales
Subscription
0015000002Ijr2RAAR
​
​
0015000002Ijr2RAAR
​
​
R&D
0015000002Ijr2R
​
Cross-doc icon
1/12/2023
EU Sales User - R&D SMB
​
Confo Therapeutics NV
Renewal 2023: Confo Therapeutics -EU - QualityDocs 10 Full & 68 RO users
4. Negotiation
Q4-2023
​
​
​
​
95
268
1/12/2023
1/12/2022
​
​
Subscription
0012J00002OMsKnQAL
​
​
0012J00002OMsKnQAL
​
​
R&D
0012J00002OMsKn
​
Cross-doc icon
1/14/2023
US Sales User - R&D SMB
Jonathan Waldvogel
Kaleido Biosciences
Renewal 2023: Kaleido Biosciences- QDocs- etMF
1. Prospecting
Q4-2023
​
​
​
​
0
266
1/14/2023
1/14/2022
​
Sales
Subscription
0015000001TUnoVAAT
​
​
0015000001TUnoVAAT
​
​
R&D
0015000001TUnoV
​
Cross-doc icon
1/17/2023
Asia Pac Sales User - R&D SMB
​
Samsung BioLogics Co., Ltd.
Renewal 2023: Samsung Biologics_KR_QD_QM_External User Liesne
3. Proposal
Q4-2023
​
​
​
​
95
263
1/17/2023
1/17/2022
​
​
Subscription
0015000001IeeNHAAZ
​
​
0015000001IeeNHAAZ
​
​
R&D
0015000001IeeNH
​
Cross-doc icon
1/18/2023
US Sales User - R&D SMB
Phil Sager
TG Therapeutics, Inc.
Renewal 2023: TG Therapeutics - QualityDocs
1. Prospecting
Q4-2023
​
​
​
​
10
262
1/18/2023
1/18/2022
​
​
Subscription
0015000000dbgxqAAA
​
​
0015000000dbgxqAAA
​
​
R&D
0015000000dbgxq
​
Cross-doc icon
1/21/2023
US Sales User - R&D ENT
​
Acceleron Pharma Inc.
Renewal 2023: Acceleron- Quality
4. Negotiation
Q4-2023
​
​
​
​
60
259
1/21/2023
1/21/2022
​
Sales
Subscription
0015000000Lq8AVAAZ
0012J00002LPcIzQAL
0012J00002LPcIzQAL
0012J00002LPcIzQAL
​
​
R&D
0015000000Lq8AV
0012J00002LPcIz
Cross-doc icon
1/21/2023
EU Sales User - CDMS
​
European Organisation for Research and Treatment of Cancer
Renewal 2023: EORTC - Safety ELA Yr 2 of 3 - 5000 cases (Renewal) - EU + ramp
4. Negotiation
Q4-2023
​
​
​
​
95
259
1/21/2023
1/21/2022
​
Sales
Subscription
0015000000wyMo2AAE
​
​
0015000000wyMo2AAE
​
​
R&D
0015000000wyMo2
​
Cross-doc icon
1/21/2023
EU Sales User - CDMS
​
European Organisation for Research and Treatment of Cancer
Renewal 2023: EORTC - ELA SSU, CTMS & eTMF -70 studies - year 2 - Renewal + Ramp
4. Negotiation
Q4-2023
​
​
​
​
95
259
1/21/2023
1/21/2022
​
Sales
Subscription
0015000000wyMo2AAE
​
​
0015000000wyMo2AAE
​
​
R&D
0015000000wyMo2
​
Cross-doc icon
1/24/2023
Asia Pac Sales User - R&D SMB
​
Samsung BioLogics Co., Ltd.
Renewal 2023: Samsung Biologics QualitySuite ELA5000
3. Proposal
Q4-2023
​
​
​
​
95
256
1/24/2023
1/24/2022
​
​
Subscription
0015000001IeeNHAAZ
​
​
0015000001IeeNHAAZ
​
​
R&D
0015000001IeeNH
​
Cross-doc icon
1/25/2023
US Sales User - R&D SMB
Christopher Mundy
CG Oncology, Inc
Renewal 2023: CG Oncology - Vault QualityDocs and Vault Training -50 ELA
4. Negotiation
Q4-2023
​
​
​
​
95
255
1/25/2023
1/25/2022
​
​
Subscription
0012J00002PxlbEQAR
​
​
0012J00002PxlbEQAR
​
​
R&D
0012J00002PxlbE
​
Cross-doc icon
1/25/2023
EU Sales User - R&D SMB
​
Santhera Pharmaceuticals (Switzerland) Ltd
Renewal 2023: Santhera - Vault QMS 25 users + 5 QDocs
3. Proposal
Q4-2023
​
​
​
​
80
255
1/25/2023
1/25/2022
​
Other
Subscription
0015000000ePgW0AAK
​
​
0015000000ePgW0AAK
​
​
R&D
0015000000ePgW0
​
Cross-doc icon
1/26/2023
EU Sales User - R&D SMB
​
Recordati S.P.A.
Renewal 2023: Recordati Add on Training for HQ- 82 Learner
4. Negotiation
Q4-2023
​
​
​
​
95
254
1/26/2023
1/26/2022
​
Sales
Subscription
0015000000VSdDeAAL
​
​
0015000000VSdDeAAL
​
​
R&D
0015000000VSdDe
​
Cross-doc icon
1/28/2023
EU Sales User - R&D SMB
​
GW Research Limited
Renewal Feb 2023: GW Pharma QualityDocs 6 months courtesy for migration access
4. Negotiation
Q4-2023
​
​
​
​
95
47
1/28/2023
8/22/2022
​
​
Subscription
0015000000ePga4AAC
0012J00002MKw19QAD
0012J00002MKw19QAD
0012J00002MKw19QAD
​
​
R&D
0015000000ePga4
0012J00002MKw19
Cross-doc icon
1/29/2023
US Sales User - MedTech ENT
​
Wright Medical Technology, Inc.
Renewal 2023: Wright Medical - eTMF renewal - 17 active
4. Negotiation
Q4-2023
​
​
​
​
95
219
1/29/2023
3/2/2022
​
​
Subscription
0015000000Lq8EoAAJ
0012J00002MKPWRQA5
0012J00002MKPWRQA5
0012J00002MKPWRQA5
​
​
R&D
0015000000Lq8Eo
0012J00002MKPWR
Cross-doc icon
1/31/2023
US Sales User - R&D SMB
Phil Sager
Celularity, Inc.
Renewal 2023: Celularity, Inc._Vault Quality Suite & Clinical
4. Negotiation
Q4-2023
​
​
​
​
95
249
1/31/2023
1/31/2022
​
Sales
Subscription
0015000001eMTROAA4
​
​
0015000001eMTROAA4
​
​
R&D
0015000001eMTRO
​
Cross-doc icon
1/31/2023
US Sales User - R&D SMB
Phil Sager
Mimedx Group, Inc.
Renewal 2022: MiMedX Vault QualityDocs and Training
1. Prospecting
Q4-2023
​
​
​
​
10
249
1/31/2023
1/31/2022
​
Sales
Subscription
0015000001EIny5AAD
​
​
0015000001EIny5AAD
​
​
R&D
0015000001EIny5
​
Cross-doc icon
1/31/2023
US Sales User - R&D SMB
Phil Sager
Myovant Sciences, Inc.
Renewal 2023: Myovant Sciences - RIM
4. Negotiation
Q4-2023
​
​
​
​
95
249
1/31/2023
1/31/2022
​
Sales
Subscription
0015000001OFSfGAAX
0012J00002MKw1cQAD
0012J00002MKw1cQAD
0012J00002MKw1cQAD
​
​
R&D
0015000001OFSfG
0012J00002OfD5X
Cross-doc icon
1/31/2023
EU Sales User - R&D ENT
​
Novartis Gene Therapies, Inc.
Renewal 2023: AveXis - eTMF renewal
4. Negotiation
Q4-2023
​
​
​
​
10
249
1/31/2023
1/31/2022
​
Sales
Subscription
0015000001IHLa0AAH
0012J00002MIzmfQAD
0012J00002MIzmfQAD
0012J00002MIzmfQAD
​
​
R&D
0015000001IHLa0
001500000133m4p
Cross-doc icon
1/31/2023
US Sales User - R&D SMB
Phil Sager
Spark Therapeutics, Inc.
Renewal 2023: Spark Therapeutics Vault Submissions
4. Negotiation
Q4-2023
​
​
​
​
95
249
1/31/2023
1/31/2022
​
​
Subscription
0015000000tq9LNAAY
0015000001nyFxKAAU
0015000001nyFxKAAU
0015000001nyFxKAAU
​
​
R&D
0015000000tq9LN
0015000001nyFxK
Cross-doc icon
1/31/2023
US Sales User - Commercial ENT
​
Elanco US Inc.
Renewal 2023: Elanco - QualityDocs & QMS ELA
4. Negotiation
Q4-2023
​
​
​
​
80
36
1/31/2023
9/1/2022
​
Sales
Subscription
0015000000KQOA1AAP
0012J00002MKyheQAD
0012J00002MKyheQAD
0012J00002MKyheQAD
​
​
R&D
0015000000KQOA1
0012J00002MKyhe
Cross-doc icon
1/31/2023
US Sales User - Commercial ENT
​
Elanco US Inc.
Renewal 2023: Elanco RIM
4. Negotiation
Q4-2023
​
​
​
​
80
36
1/31/2023
9/1/2022
​
Sales
Subscription
0015000000KQOA1AAP
0012J00002MKyheQAD
0012J00002MKyheQAD
0012J00002MKyheQAD
​
​
R&D
0015000000KQOA1
0012J00002MKyhe
Cross-doc icon
2/1/2023
US Sales User - MedTech ENT
​
Abbott MedTech
Renewal 2023: Abbott ARDx - NA - RIM - Publishing
2. Discovery
Q1-2024
​
​
​
​
98
276
2/1/2023
1/4/2022
​
Sales
Subscription
0012J00002ZERRwQAP
0012J00002MK4X8QAL
0012J00002MK4X8QAL
0012J00002MK4X8QAL
​
​
R&D
0012J00002ZERRw
0012J00002MK4X8
Cross-doc icon
2/1/2023
Asia Pac Sales User - R&D SMB
​
Samsung Bioepis Co.,Ltd
Renewal 2023: SBE Vault QMS
Closed Won
Q1-2024
​
​
​
​
100
716
2/1/2023
2/15/2021
​
​
Renewal
0015000001XqSccAAF
0015000001IeeNHAAZ
0015000001IeeNHAAZ
0015000001IeeNHAAZ
QMS
Vault
R&D
0015000001XqScc
0015000001IeeNH
Cross-doc icon
2/1/2023
Operations
​
Cognizant
Renewal 2023: Cognizant-RENEWAL Vault Platform-BPASS
4. Negotiation
Q1-2024
​
​
​
​
95
220
2/1/2023
3/1/2022
​
​
Subscription
0012J00002aBpFVQA0
​
​
0012J00002aBpFVQA0
​
​
R&D
0012J00002aBpFV
​
Cross-doc icon
2/1/2023
EU Sales User - R&D SMB
​
Oncopeptides AB
Renewal 2023: Oncopeptides Safety
4. Negotiation
Q1-2024
​
​
​
​
99
246
2/1/2023
2/3/2022
​
Sales
Subscription
0015000001RQkXdAAL
​
​
0015000001RQkXdAAL
​
​
R&D
0015000001RQkXd
​
Cross-doc icon
2/1/2023
US Sales User - R&D ENT
​
J&J Pharmaceuticals
Renewal 2023: Johnson & Johnson eTMF - Med Tech/Device
4. Negotiation
Q1-2024
​
​
​
​
95
214
2/1/2023
3/7/2022
​
​
Subscription
0012J00002MJmrHQAT
0015000001RO8AFAA1
0015000001RO8AFAA1
0015000001RO8AFAA1
​
​
R&D
0012J00002MJmrH
0015000001RO8AF
Cross-doc icon
2/1/2023
US Sales User - R&D ENT
​
J&J Pharmaceuticals
Renewal 2023: Johnson & Johnson eTMF - Pharma
4. Negotiation
Q1-2024
​
​
​
​
95
214
2/1/2023
3/7/2022
​
​
Subscription
0012J00002MJmrHQAT
0015000001RO8AFAA1
0015000001RO8AFAA1
0015000001RO8AFAA1
​
​
R&D
0012J00002MJmrH
0015000001RO8AF
Cross-doc icon
2/2/2023
US Sales User - CRO
​
Syneos
Renewal 2023: GSK CH 218220 / SH 7035160
4. Negotiation
Q1-2024
​
​
​
​
99
274
2/2/2023
1/6/2022
​
Sales
Subscription
0012J00002MKPWbQAP
​
​
0012J00002MKPWbQAP
​
​
R&D
0012J00002MKPWb
​
Cross-doc icon
2/2/2023
US Sales User - R&D SMB
Phil Sager
Precigen, Inc.
Renewal 2023: Precigen - Clinical, Quality & RIM US
4. Negotiation
Q1-2024
​
​
​
​
95
247
2/2/2023
2/2/2022
​
​
Subscription
0015000001Q1vehAAB
​
​
0015000001Q1vehAAB
​
​
R&D
0015000001Q1veh
​
Cross-doc icon
2/2/2023
US Sales User - R&D SMB
Phil Sager
Precigen, Inc.
Renewal 2023: Precigen - Clinical, Quality & RIM EU
4. Negotiation
Q1-2024
​
​
​
​
95
247
2/2/2023
2/2/2022
​
​
Subscription
0015000001Q1vehAAB
​
​
0015000001Q1vehAAB
​
​
R&D
0015000001Q1veh
​
Cross-doc icon
2/3/2023
US Sales User - R&D SMB
Adam De Oliveira
VYNE Therapeutics Inc.
Renewal 2023: VYNE Pharmaceuticals - Vault QualityDocs/QMS/Training 200 Employee ELA
2. Discovery
Q1-2024
​
​
​
​
20
246
2/3/2023
2/3/2022
​
​
Subscription
0015000000ePgS0AAK
​
​
0015000000ePgS0AAK
​
​
R&D
0015000000ePgS0
​
Cross-doc icon
2/4/2023
US Sales User - R&D SMB
Adam De Oliveira
Scynexis, Inc.
Renewal 2023: Scynexis (New Logo) QualityDocs
4. Negotiation
Q1-2024
​
​
​
​
95
245
2/4/2023
2/4/2022
​
​
Subscription
0015000000iSC2xAAG
​
​
0015000000iSC2xAAG
​
​
R&D
0015000000iSC2x
​
Cross-doc icon
2/7/2023
US Sales User - R&D SMB
Adam De Oliveira
TherapeuticsMD, Inc.
Renewal 2023: TherapeuticsMD Vault Renewals
4. Negotiation
Q1-2024
​
​
​
​
95
242
2/7/2023
2/7/2022
​
​
Subscription
0015000000dbU1sAAE
​
​
0015000000dbU1sAAE
​
​
R&D
0015000000dbU1s
​
Cross-doc icon
2/7/2023
EU Sales User - MedTech ENT
​
Galvani Bioelectronics Limited
Renewal 2023: Galvani eTMF
4. Negotiation
Q1-2024
​
​
​
​
95
242